91 TOLL LIKE RECEPTOR 4 ANTAGONIST PREVENTS ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE IN MICE: A NOVEL THERAPEUTIC STRATEGY (English)
- New search for: Shah, N.
- New search for: Dhar, D.
- New search for: Jover, M.
- New search for: Davies, N. A.
- New search for: Mookerjee, R. P.
- New search for: Jalan, R.
- New search for: Shah, N.
- New search for: Dhar, D.
- New search for: Jover, M.
- New search for: Davies, N. A.
- New search for: Mookerjee, R. P.
- New search for: Jalan, R.
In:
JOURNAL OF HEPATOLOGY
;
56
;
S39-S40
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:91 TOLL LIKE RECEPTOR 4 ANTAGONIST PREVENTS ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE IN MICE: A NOVEL THERAPEUTIC STRATEGY
-
Contributors:Shah, N. ( author ) / Dhar, D. ( author ) / Jover, M. ( author ) / Davies, N. A. ( author ) / Mookerjee, R. P. ( author ) / Jalan, R. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 56 ; S39-S40
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2012-01-01
-
Size:S39-S40
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 56
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
FocusFriedman, Scott L. et al. | 2012
- 4
-
The Journal of Hepatology: An international journal in a new eraSamuel, Didier et al. | 2012
- 5
-
Get ActiveThursz, M. et al. | 2012
- 7
-
IL-33 - A cytokine which balances on a knife's edge?Erhardt, A. / Tiegs, G. et al. | 2012
- 11
-
The invaders and the barrierPawlotsky, J. M. et al. | 2012
- 14
-
Salvage liver transplantation for recurrent hepatocellular carcinoma after radiofrequency ablation: A new strategy?Kelley, Robin K. / Yao, Francis et al. | 2012
- 17
-
Who pulls the trigger: JNK activation in liver lipotoxicity?Ibrahim, Samar H. / Gores, Gregory J. et al. | 2012
- 20
-
Chronic intermittent hypoxia: A breath of fresh air in the understanding of NAFLD pathogenesisLemoine, M. / Serfaty, L. et al. | 2012
- 23
-
Touching some firm ground in the epidemiology of NASHRatziu, Vlad / Voiculescu, Mihai / Poynard, Thierry et al. | 2012
- 26
-
Protective role of IL-33/ST2 axis in Con A-induced hepatitisVolarevic, V. / Mitrovic, M. / Milovanovic, M. / Zelen, I. / Nikolic, I. / Mitrovic, S. / Pejnovic, N. / Arsenijevic, N. / Lukic, M. L. et al. | 2012
- 34
-
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirinHuang, Chung-Feng / Huang, Jee-Fu / Yang, Jeng-Fu / Hsieh, Ming-Yen / Lin, Zu-Yau / Chen, Shinn-Cherng / Wang, Liang-Yen / Juo, Suh-Hang Hank / Chen, Ku-Chung / Chuang, Wan-Long et al. | 2012
- 41
-
In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitorsDelang, Leen / Vliegen, Inge / Leyssen, Pieter / Neyts, Johan et al. | 2012
- 49
-
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysisIngiliz, P. / Valantin, M. A. / Preziosi, P. / Finzi, L. / Pais, R. / Fedchuk, L. / Dominguez, S. / Katlama, C. / Poynard, T. / Benhamou, Y. et al. | 2012
- 55
-
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 studyZarski, J. P. / Sturm, N. / Guechot, J. / Paris, A. / Zafrani, E. S. / Asselah, T. / Boisson, R. C. / Bosson, J. L. / Guyader, D. / Renversez, J. C. et al. | 2012
- 63
-
Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseasesLee, Seoung-Ae / Kim, Kijeong / Kim, Hong / Kim, Bum-Joon et al. | 2012
- 70
-
Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patientsJouan, L. / Chatel-Chaix, L. / Melancon, P. / Rodrigue-Gervais, I. G. / Raymond, V. A. / Selliah, S. / Bilodeau, M. / Grandvaux, N. / Lamarre, D. et al. | 2012
- 78
-
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in JapanKumada, H. / Toyota, J. / Okanoue, T. / Chayama, K. / Tsubouchi, H. / Hayashi, N. et al. | 2012
- 85
-
Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitisEnomoto, Hirayuki / Inoue, Shin-ichi / Matsuhisa, Akio / Aizawa, Nobuhiro / Imanishi, Hiroyasu / Saito, Masaki / Iwata, Yoshinori / Tanaka, Hironori / Ikeda, Naoto / Sakai, Yoshiyuki et al. | 2012
- 95
-
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an Intensive Care UnitLevesque, Eric / Hoti, Emir / Azoulay, Daniel / Ichaï, Philippe / Habouchi, Houssam / Castaing, Denis / Samuel, Didier / Saliba, Faouzi et al. | 2012
- 103
-
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumorsLlop, E. / Berzigotti, A. / Reig, M. / Erice, E. / Reverter, E. / Seijo, S. / Abraldes, J. G. / Bruix, J. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2012
- 109
-
Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosisOria, M. / Romero-Gimenez, J. / Arranz, J. A. / Riudor, E. / Raguer, N. / Cordoba, J. et al. | 2012
- 115
-
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantationMederacke, I. / Filmann, N. / Yurdaydin, C. / Bremer, B. / Puls, F. / Zacher, B. J. / Heidrich, B. / Tillmann, H. L. / Rosenau, J. / Bock, C. T. et al. | 2012
- 123
-
Threshold for toxicity from hyperammonemia in critically ill childrenOzanne, B. / Nelson, J. / Cousineau, J. / Lambert, M. / Phan, V. / Mitchell, G. / Alvarez, F. / Ducruet, T. / Jouvet, P. et al. | 2012
- 129
-
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastographyStravitz, R. T. / Lisman, T. / Luketic, V. A. / Sterling, R. K. / Puri, P. / Fuchs, M. / Ibrahim, A. / Lee, W. M. / Sanyal, A. J. et al. | 2012
- 137
-
Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusionShi, Y. / Rehman, H. / Ramshesh, V. K. / Schwartz, J. / Liu, Q. / Krishnasamy, Y. / Zhang, X. / Lemasters, J. J. / Smith, C. D. / Zhong, Z. et al. | 2012
- 146
-
Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liverKuroda, S. / Tashiro, H. / Igarashi, Y. / Tanimoto, Y. / Nambu, J. / Oshita, A. / Kobayashi, T. / Amano, H. / Tanaka, Y. / Ohdan, H. et al. | 2012
- 153
-
FGL2/Fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in miceSelzner, N. / Liu, H. / Boehnert, M. U. / Adeyi, O. A. / Shalev, I. / Bartczak, A. M. / Xue-Zhong, M. / Manuel, J. / Rotstein, O. D. / McGilvray, I. D. et al. | 2012
- 160
-
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosisN'Kontchou, G. / Aout, M. / Laurent, A. / Nahon, P. / Ganne-Carrie, N. / Grando, V. / Baghad, I. / Roulot, D. / Trinchet, J. C. / Sellier, N. et al. | 2012
- 167
-
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinomaTomimaru, Y. / Eguchi, H. / Nagano, H. / Wada, H. / Kobayashi, S. / Marubashi, S. / Tanemura, M. / Tomokuni, A. / Takemasa, I. / Umeshita, K. et al. | 2012
- 176
-
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoShao, H. / Gao, C. / Tang, H. / Zhang, H. / Roberts, L. R. / Hylander, B. L. / Repasky, E. A. / Ma, W. W. / Qiu, J. / Adjei, A. A. et al. | 2012
- 184
-
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activationNault, J. C. / Fabre, M. / Couchy, G. / Pilati, C. / Jeannot, E. / Tran Van Nhieu, J. / Saint-Paul, M. C. / De Muret, A. / Redon, M. J. / Buffet, C. et al. | 2012
- 192
-
Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytesSharma, Manju / Urano, Fumihiko / Jaeschke, Anja et al. | 2012
- 199
-
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liverDentin, Renaud / Tomas-Cobos, Lidia / Foufelle, Fabienne / Leopold, Jane / Girard, Jean / Postic, Catherine / Ferré, Pascal et al. | 2012
- 210
-
SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolismChen, T. / Chen, Q. / Xu, Y. / Zhou, Q. / Zhu, J. / Zhang, H. / Wu, Q. / Xu, J. / Yu, C. et al. | 2012
- 218
-
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosisCorpechot, Christophe / Gaouar, Farid / Chrétien, Yves / Johanet, Catherine / Chazouillères, Olivier / Poupon, Raoul et al. | 2012
- 225
-
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obeseAron-Wisnewsky, J. / Minville, C. / Tordjman, J. / Levy, P. / Bouillot, J. L. / Basdevant, A. / Bedossa, P. / Clement, K. / Pepin, J. L. et al. | 2012
- 234
-
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortArmstrong, Matthew J. / Houlihan, Diarmaid D. / Bentham, Louise / Shaw, Jean C. / Cramb, Robert / Olliff, Simon / Gill, Paramjit S. / Neuberger, James M. / Lilford, Richard J. / Newsome, Philip N. et al. | 2012
- 241
-
Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver diseaseYu, Chaohui / Xu, Chengfu / Xu, Lei / Yu, Jiekai / Miao, Min / Li, Youming et al. | 2012
- 248
-
Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in miceSong, Yiyun / Shan, Shifang / Zhang, Ying / Liu, Wei / Ding, Weiqiao / Ren, Wenxia / Xia, Hongfeng / Li, Xiaojun / Zhang, Qin / Zhao, Lei et al. | 2012
- 255
-
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic reviewThoma, C. / Day, C. P. / Trenell, M. I. et al. | 2012
- 267
-
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): An emerging field for advanced technologiesMarquardt, J. U. / Galle, P. R. / Teufel, A. et al. | 2012
- 276
-
Peginterferon maintenance therapy in patients with advanced hepatitis C to prevent hepatocellular carcinoma: The plot thickensAghemo, A. / Colombo, M. et al. | 2012
- 279
-
Novel insights in the genetics of HCC recurrence and advances in transcriptomic data integrationTeufel, A. / Marquardt, J. U. / Galle, P. R. et al. | 2012
- 282
-
Adding to the toolbox: Receptor tyrosine kinases as potential targets in the treatment of hepatitis CJilg, Nikolaus / Chung, Raymond T. et al. | 2012
- 285
-
Sirolimus - It doesn't deserve its bad Rap(a)McKenna, G. J. / Trotter, J. F. et al. | 2012
- 288
-
The use of Sirolimus should be restricted in liver transplantationMassoud, Omar / Wiesner, Russell H. et al. | 2012
- 291
-
Lipotoxicity in NASHFuchs, Michael / Sanyal, Arun J. et al. | 2012
- 294
-
Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failureVedrenne, V. / Galmiche, L. / Chretien, D. / de Lonlay, P. / Munnich, A. / Rotig, A. et al. | 2012
- 298
-
Betablockers induce cardiac chronotropic incompetenceKrag, A. / Moller, S. / Burroughs, A. K. / Bendtsen, F. et al. | 2012
- 299
-
Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot studyShimada, Masahiko / Yoshida, Shuhei / Masuzaki, Ryota / Schuppan, Detlef et al. | 2012
- 300
-
Smoking and NASH: A hidden message from the GREACE trialBabu, M. / Paul, N. et al. | 2012
- 301
-
Reply to: “Smoking and NASH: A hidden message from the GREACE trial”Zein, Claudia O. / McCullough, Arthur J. / Unalp, Aynur et al. | 2012
- 305
-
Yes! Statins can be given to liver patientsBader, T. et al. | 2012
- 308
-
NKG2D and its ligands: Key to immunotherapy of liver cancer?Mondelli, M. U. et al. | 2012
- 311
-
HIF-1a is a major and complex player in alcohol induced liver diseasesMehal, W. Z. et al. | 2012
- 313
-
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patientsThompson, A. J. / Clark, P. J. / Singh, A. / Ge, D. / Fellay, J. / Zhu, M. / Zhu, Q. / Urban, T. J. / Patel, K. / Tillmann, H. L. et al. | 2012
- 320
-
Gaps in the achievement of effectiveness of HCV treatment in national VA practiceKramer, J. R. / Kanwal, F. / Richardson, P. / Mei, M. / El-Serag, H. B. et al. | 2012
- 326
-
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virusZhao, H. / Lin, W. / Kumthip, K. / Cheng, D. / Fusco, D. N. / Hofmann, O. / Jilg, N. / Tai, A. W. / Goto, K. / Zhang, L. et al. | 2012
- 334
-
A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuseLe Lan, C. / Guillygomarc'h, A. / Danielou, H. / Le Dreau, G. / Laine, F. / Vedeilhie, C. / Deugnier, Y. / Brissot, P. / Guyader, D. / Moirand, R. et al. | 2012
- 341
-
Hyporesponsiveness to PegIFNa2B plus ribavirin in patients with hepatitis C-related advanced fibrosisPrati, G. M. / Aghemo, A. / Rumi, M. G. / D'Ambrosio, R. / De Nicola, S. / Donato, M. F. / Degasperi, E. / Colombo, M. et al. | 2012
- 348
-
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot studySingh, V. / Dhungana, S. P. / Singh, B. / Vijayverghia, R. / Nain, C. K. / Sharma, N. / Bhalla, A. / Gupta, P. K. et al. | 2012
- 355
-
Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantationCoto-Llerena, M. / Crespo, G. / Gonzalez, P. / Koutsoudakis, G. / Miquel, R. / Navasa, M. / Forns, X. / Perez-del-Pulgar, S. et al. | 2012
- 359
-
HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through PI3K/PTEN signalingKe, B. / Shen, X. D. / Ji, H. / Kamo, N. / Gao, F. / Freitas, M. C. / Busuttil, R. W. / Kupiec-Weglinski, J. W. et al. | 2012
- 367
-
Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in miceFernandez-Barrena, M. G. / Monte, M. J. / Latasa, M. U. / Uriarte, I. / Vicente, E. / Chang, H. C. / Rodriguez-Ortigosa, C. M. / Elferink, R. O. / Berasain, C. / Marin, J. J. et al. | 2012
- 374
-
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketingBjornsson, E. / Jacobsen, E. I. / Kalaitzakis, E. et al. | 2012
- 381
-
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrenceKamimura, H. / Yamagiwa, S. / Tsuchiya, A. / Takamura, M. / Matsuda, Y. / Ohkoshi, S. / Inoue, M. / Wakai, T. / Shirai, Y. / Nomoto, M. et al. | 2012
- 389
-
MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinomaLiu, S. / Guo, W. / Shi, J. / Li, N. / Yu, X. / Xue, J. / Fu, X. / Chu, K. / Lu, C. / Zhao, J. et al. | 2012
- 397
-
The changing scenario of hepatocellular carcinoma over the last two decades in ItalySanti, V. / Buccione, D. / Di Micoli, A. / Fatti, G. / Frigerio, M. / Farinati, F. / Del Poggio, P. / Rapaccini, G. / Di Nolfo, M. A. / Benvegnu, L. et al. | 2012
- 406
-
Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinomaShim, J. H. / Lee, H. C. / Won, H. J. / Shin, Y. M. / Kim, K. M. / Lim, Y. S. / Suh, D. J. et al. | 2012
- 412
-
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinomaWang, J. H. / Wang, C. C. / Hung, C. H. / Chen, C. L. / Lu, S. N. et al. | 2012
- 419
-
Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafishLi, Z. / Huang, X. / Zhan, H. / Zeng, Z. / Li, C. / Spitsbergen, J. M. / Meierjohann, S. / Schartl, M. / Gong, Z. et al. | 2012
- 426
-
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosisNahon, P. / Sutton, A. / Rufat, P. / Charnaux, N. / Mansouri, A. / Moreau, R. / Ganne-Carrie, N. / Grando-Lemaire, V. / N'Kontchou, G. / Trinchet, J. C. et al. | 2012
- 433
-
High fructose feeding induces copper deficiency in Sprague-Dawley rats: A novel mechanism for obesity related fatty liverSong, M. / Schuschke, D. A. / Zhou, Z. / Chen, T. / Pierce, W. M. / Wang, R. / Johnson, W. T. / McClain, C. J. et al. | 2012
- 441
-
HIF-1a induction suppresses excessive lipid accumulation in alcoholic fatty liver in miceNishiyama, Y. / Goda, N. / Kanai, M. / Niwa, D. / Osanai, K. / Yamamoto, Y. / Senoo-Matsuda, N. / Johnson, R. S. / Miura, S. / Kabe, Y. et al. | 2012
- 448
-
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studiesAl-Serri, A. / Anstee, Q. M. / Valenti, L. / Nobili, V. / Leathart, J. B. / Dongiovanni, P. / Patch, J. / Fracanzani, A. / Fargion, S. / Day, C. P. et al. | 2012
- 455
-
Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antiviralsCacoub, P. / Bourliere, M. / Lubbe, J. / Dupin, N. / Buggisch, P. / Dusheiko, G. / Hezode, C. / Picard, O. / Pujol, R. / Segaert, S. et al. | 2012
- 464
-
Radioembolization for hepatocellular carcinomaSangro, B. / Inarrairaegui, M. / Bilbao, J. I. et al. | 2012
- 474
-
Liver transplantation using Donation after Cardiac Death donorsMonbaliu, D. / Pirenne, J. / Talbot, D. et al. | 2012
- 486
-
Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinomaGarcia, J. A. / Roberts, L. R. et al. | 2012
- 488
-
Back to basics: Staging and prognosis in HCC for medical oncologistPeck-Radosavljevic, M. et al. | 2012
- 490
-
EpCAM in hepatocytes and their progenitorsGires, O. et al. | 2012
- 493
-
Chimeric mouse model of hepatitis B virus infectionDandri, M. / Petersen, J. et al. | 2012
- 496
-
New horizons for stem cell therapy in liver diseaseForbes, S. J. / Newsome, P. N. et al. | 2012
- 500
-
Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipientSchlosser, B. / Stein, A. / Neuhaus, R. / Pahl, S. / Ramez, B. / Kruger, D. H. / Berg, T. / Hofmann, J. et al. | 2012
- 503
-
The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practiceWeiss, J. J. / Alcorn, M. C. / Rabkin, J. G. / Dieterich, D. T. et al. | 2012
- 504
-
Herbal medicine hepatotoxicity revisitedAppelhans, K. / Frankos, V. et al. | 2012
- 505
-
Reply to: "Herbal medicine hepatotoxicity revisited"Larrey, D. / Faure, S. et al. | 2012
- 506
-
Reply to: "Ammonia and cerebral water. Importance of structural analysis of the brain in hepatic encephalopathy"Smith, F. E. / Mardini, H. / Record, C. O. / Blamire, A. M. et al. | 2012
- 506
-
Ammonia and cerebral water. Importance of structural analysis of the brain in hepatic encephalopathyMcPhail, M. J. / Dhanjal, N. S. / Grover, V. P. / Taylor-Robinson, S. D. et al. | 2012
- 507
-
C reactive protein levels in non-alcoholic fatty liver diseaseDogru, T. / Genc, H. / Bagci, S. et al. | 2012
- 508
-
Reply to: "C-reactive protein levels in non-alcoholic fatty liver disease"Jess, T. / Zimmermann, E. / Anty, R. / Tordjman, J. / Verrijken, A. / Gual, P. / Tran, A. / Iannelli, A. / Gugenheim, J. / Bedosa, P. et al. | 2012
- 513
-
Hepatitis C treatment - Clearing the mindForton, D. M. et al. | 2012
- 515
-
Liver-induced inflammation hurts the brainGarcia-Martinez, Rita / Cordoba, Juan et al. | 2012
- 518
-
p53-Mediated regulation of hepatic lipid metabolism: Forging links between metabolism, atherogenesis, and cancerStratton, S. A. / Barton, M. C. et al. | 2012
- 520
-
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort studyPetersen, J. / Ratziu, V. / Buti, M. / Janssen, H. L. / Brown, A. / Lampertico, P. / Schollmeyer, J. / Zoulim, F. / Wedemeyer, H. / Sterneck, M. et al. | 2012
- 527
-
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CAsselah, Tarik / De Muynck, Simon / Broët, Philippe / Masliah-Planchon, Julien / Blanluet, Maud / Bièche, Ivan / Lapalus, Martine / Martinot-Peignoux, Michelle / Lada, Olivier / Estrabaud, Emilie et al. | 2012
- 533
-
Hepatitis B virus infection and fatty liver in the general populationWong, V. W. / Wong, G. L. / Chu, W. C. / Chim, A. M. / Ong, A. / Yeung, D. K. / Yiu, K. K. / Chu, S. H. / Chan, H. Y. / Woo, J. et al. | 2012
- 541
-
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standardPoynard, Thierry / de Ledinghen, Victor / Zarski, Jean Pierre / Stanciu, Carol / Munteanu, Mona / Vergniol, Julien / France, Julie / Trifan, Anca / Le Naour, Gilles / Vaillant, Jean Christophe et al. | 2012
- 549
-
Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognitionByrnes, V. / Miller, A. / Lowry, D. / Hill, E. / Weinstein, C. / Alsop, D. / Lenkinski, R. / Afdhal, N. H. et al. | 2012
- 557
-
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1Howell, C. D. / Gorden, A. / Ryan, K. A. / Thompson, A. J. / Ibrahim, C. / Fried, M. / Afdhal, N. H. / McHutchison, J. G. / Shianna, K. V. / Goldstein, D. B. et al. | 2012
- 564
-
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probeMyers, R. P. / Pomier-Layrargues, G. / Kirsch, R. / Pollett, A. / Beaton, M. / Levstik, M. / Duarte-Rojo, A. / Wong, D. / Crotty, P. / Elkashab, M. et al. | 2012
- 571
-
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosisCárdenas, Andrés / Ginès, Pere / Marotta, Paul / Czerwiec, Frank / Oyuang, John / Guevara, Mónica / Afdhal, Nezam H et al. | 2012
- 579
-
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor poolLoggi, Elisabetta / Micco, Lorenzo / Ercolani, Giorgio / Cucchetti, Alessandro / Bihl, Florian K. / Grazi, Gian Luca / Gitto, Stefano / Bontadini, Andrea / Bernardi, Mauro / Grossi, Paolo et al. | 2012
- 586
-
PPARa is down-regulated following liver transplantation in miceNakagawa, K. / Tanaka, N. / Morita, M. / Sugioka, A. / Miyagawa, S. i. / Gonzalez, F. J. / Aoyama, T. et al. | 2012
- 586
-
PPARα is down-regulated following liver transplantation in miceNakagawa, Kan / Tanaka, Naoki / Morita, Miwa / Sugioka, Atsushi / Miyagawa, Shin-ichi / Gonzalez, Frank J. / Aoyama, Toshifumi et al. | 2012
- 595
-
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinomaHuynh, H. / Chow, P. K. / Tai, W. M. / Choo, S. P. / Chung, A. Y. / Ong, H. S. / Soo, K. C. / Ong, R. / Linnartz, R. / Shi, M. M. et al. | 2012
- 602
-
Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis CKurosaki, M. / Hiramatsu, N. / Sakamoto, M. / Suzuki, Y. / Iwasaki, M. / Tamori, A. / Matsuura, K. / Kakinuma, S. / Sugauchi, F. / Sakamoto, N. et al. | 2012
- 609
-
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beadsGuiu, Boris / Deschamps, Frédéric / Aho, Serge / Munck, Flore / Dromain, Clarisse / Boige, Valérie / Malka, David / Leboulleux, Sophie / Ducreux, Michel / Schlumberger, Martin et al. | 2012
- 618
-
Impact of geographic disparity on liver allocation for hepatocellular cancer in the United StatesKadry, Z. / Schaefer, E. W. / Uemura, T. / Shah, A. R. / Schreibman, I. / Riley, T. R. et al. | 2012
- 626
-
Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic miceNguyen, Kimchi / D’Mello, Charlotte / Le, Tai / Urbanski, Stefan / Swain, Mark G. et al. | 2012
- 632
-
Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosisMonsénégo, Julia / Mansouri, Abdelhak / Akkaoui, Marie / Lenoir, Véronique / Esnous, Catherine / Fauveau, Véronique / Tavernier, Valentin / Girard, Jean / Prip-Buus, Carina et al. | 2012
- 640
-
The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasisUrdzik, Jozef / Bjerner, Tomas / Wanders, Alkwin / Weis, Jan / Duraj, Frans / Haglund, Ulf / Norén, Agneta et al. | 2012
- 647
-
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosisGaens, Katrien H.J. / Niessen, Petra M.G. / Rensen, Sander S. / Buurman, Wim A. / Greve, Jan Willem M. / Driessen, Ann / Wolfs, Marcel G.M. / Hofker, Marten H. / Bloemen, Johanne G. / Dejong, Cornelis H. et al. | 2012
- 656
-
p53, a novel regulator of lipid metabolism pathwaysGoldstein, I. / Ezra, O. / Rivlin, N. / Molchadsky, A. / Madar, S. / Goldfinger, N. / Rotter, V. et al. | 2012
- 663
-
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humansPihlajamäki, Jussi / Kuulasmaa, Tiina / Kaminska, Dorota / Simonen, Marko / Kärjä, Vesa / Grönlund, Sari / Käkelä, Pirjo / Pääkkönen, Matti / Kainulainen, Sakari / Punnonen, Kari et al. | 2012
- 671
-
EASL Clinical Practice Guidelines: Wilson’s disease| 2012
- 686
-
Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?Asghar, U. / Meyer, T. et al. | 2012
- 696
-
Non invasive evaluation of portal hypertension using transient elastographyCastera, L. / Pinzani, M. / Bosch, J. et al. | 2012
- 704
-
Obesity, inflammation, and liver cancerSun, B. / Karin, M. et al. | 2012
- 714
-
The adolescent and liver transplantationBurra, Patrizia et al. | 2012
- 723
-
Sorafenib use while waiting for liver transplant: We still need to waitFinn, Richard S. et al. | 2012
- 726
-
A dive into the complexity of type I interferon antiviral functionsTouzot, M. / Soumelis, V. / Asselah, T. et al. | 2012
- 729
-
Genomic risk of hepatitis C-related hepatocellular carcinomaHoshida, Yujin / Fuchs, Bryan C. / Tanabe, Kenneth K. et al. | 2012
- 731
-
Towards common denominators in primary biliary cirrhosis: The role of IL-12Lleo, A. / Gershwin, M. E. / Mantovani, A. / Invernizzi, P. et al. | 2012
- 734
-
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her motherNiederhauser, C. / Candotti, D. / Weingand, T. / Maier, A. / Tinguely, C. / Stolz, M. / Allain, J. P. et al. | 2012
- 738
-
Favorable association between genetic polymorphisms near the IL28B gene and hepatic steatosis: Direct or indirect?Toyoda, Hidenori / Kumada, Takashi et al. | 2012
- 739
-
Reply to: “Favorable association between genetic polymorphisms near the IL28B gene and hepatic steatosis: Direct or indirect?”Tillmann, Hans Ludger / McCarthy, Jeanette J. et al. | 2012
- 740
-
Acoustic radiation force-based shear stiffness and non-invasive panels of tests in Japanese patients with nonalcoholic fatty liver diseaseYoneda, M. / Imajo, K. / Kirikoshi, H. / Nakajima, A. et al. | 2012
- 741
-
IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-α sensitivity devoid from classical interferon-α side effects?Orlent, Hans / de Knegt, Robert J. / Janssen, Harry L.A. et al. | 2012
- 741
-
IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-a sensitivity devoid from classical interferon-a side effects?Orlent, H. / de Knegt, R. J. / Janssen, H. L. et al. | 2012
- 742
-
Reply to “IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-α sensitivity devoid from classical interferon-α side effects?”Thompson, A.J. / Clark, P.J. / Muir, A.J. / Sulkowski, M.S. et al. | 2012
- 742
-
Reply to "IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-a sensitivity devoid from classical interferon-a side effects?"Thompson, A. J. / Clark, P. J. / Muir, A. J. / Sulkowski, M. S. et al. | 2012
- 743
-
Transient elevation of serum bile salts after partial hepatectomy is due to metabolic overload and not to cholestasisJansen, P. L. et al. | 2012
- 744
-
Reply to: "Transient elevation of serum bile salts after partial hepatectomy is due to metabolic overload and not to cholestasis"Miura, T. / Kimura, N. / Yamana, D. / Hakamada, K. / Tsuchida, S. / Yamada, T. / Shimizu, T. / Nanashima, N. et al. | 2012
- 745
-
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: Results from ANRS CO13 HEPAVIHCarrieri, M. Patrizia / Cohen, Julien / Salmon-Ceron, Dominique / Winnock, Maria et al. | 2012
- 748
-
Corrigendum to “IL-1 cytokine family members and NAFLD: Neglected in metabolic liver inflammation” [J Hepatol 2011;55:960–962]Tilg, Herbert / Moschen, Alexander R. et al. | 2012
- 749
-
Erratum to "Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility" [J Hepatol 2011; 54: 1205-1213]Li, C. / Zheng, S. / You, H. / Liu, X. / Lin, M. / Yang, L. / Li, L. et al. | 2012
- 753
-
Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: A need for more translational studyLau, G. K. / Wang, F. S. et al. | 2012
- 756
-
Bacterial resistance in cirrhotic patients: An emerging realityMerli, M. / Lucidi, C. et al. | 2012
- 758
-
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsNischalke, H. D. / Berger, C. / Luda, C. / Muller, T. / Berg, T. / Coenen, M. / Kramer, B. / Korner, C. / Trebicka, J. / Grunhage, F. et al. | 2012
- 765
-
T cell responses and viral variability in blood donation candidates with occult hepatitis B infectionBes, M. / Vargas, V. / Piron, M. / Casamitjana, N. / Esteban, J. I. / Vilanova, N. / Pinacho, A. / Quer, J. / Puig, L. / Guardia, J. et al. | 2012
- 775
-
High serum IL-21 levels after 12weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis BMa, S. W. / Huang, X. / Li, Y. Y. / Tang, L. B. / Sun, X. F. / Jiang, X. T. / Zhang, Y. X. / Sun, J. / Liu, Z. H. / Abbott, W. G. et al. | 2012
- 782
-
13C-Aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis CRocco, A. / de Nucci, G. / Valente, G. / Compare, D. / D'Arienzo, A. / Cimino, L. / Perri, F. / Nardone, G. et al. | 2012
- 788
-
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadNeukam, K. / Camacho, A. / Caruz, A. / Rallon, N. / Torres-Cornejo, A. / Rockstroh, J. K. / Macias, J. / Rivero, A. / Benito, J. M. / Lopez-Cortes, L. F. et al. | 2012
- 795
-
Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversionNie, H. / Evans, A. A. / London, W. T. / Block, T. M. / Ren, X. D. et al. | 2012
- 803
-
A dual role for hypoxia inducible factor-1a in the hepatitis C virus lifecycle and hepatoma migrationWilson, G. K. / Brimacombe, C. L. / Rowe, I. A. / Reynolds, G. M. / Fletcher, N. F. / Stamataki, Z. / Bhogal, R. H. / Simoes, M. L. / Ashcroft, M. / Afford, S. C. et al. | 2012
- 810
-
Renal failure and cirrhosis: A systematic review of mortality and prognosisFede, G. / D'Amico, G. / Arvaniti, V. / Tsochatzis, E. / Germani, G. / Georgiadis, D. / Morabito, A. / Burroughs, A. K. et al. | 2012
- 819
-
Short course adjuvant terlipressin in acute variceal bleeding: A randomized double blind dummy controlled trialAzam, Z. / Hamid, S. / Jafri, W. / Salih, M. / Abbas, Z. / Abid, S. / Shah, H. et al. | 2012
- 825
-
Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitisAriza, X. / Castellote, J. / Lora-Tamayo, J. / Girbau, A. / Salord, S. / Rota, R. / Ariza, J. / Xiol, X. et al. | 2012
- 833
-
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScande Ledinghen, V. / Wong, V. W. / Vergniol, J. / Wong, G. L. / Foucher, J. / Chu, S. H. / Le Bail, B. / Choi, P. C. / Chermak, F. / Yiu, K. K. et al. | 2012
- 840
-
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipientsSebagh, M. / Samuel, D. / Antonini, T. M. / Coilly, A. / Degli Esposti, D. / Roche, B. / Karam, V. / Dos Santos, A. / Duclos-Vallee, J. C. / Roque-Afonso, A. M. et al. | 2012
- 848
-
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?Khan, S. A. / Emadossadaty, S. / Ladep, N. G. / Thomas, H. C. / Elliott, P. / Taylor-Robinson, S. D. / Toledano, M. B. et al. | 2012
- 855
-
Transcriptional regulation of miR-224 upregulated in human HCCs by NFkB inflammatory pathwaysScisciani, C. / Vossio, S. / Guerrieri, F. / Schinzari, V. / De Iaco, R. / D'Onorio de Meo, P. / Cervello, M. / Montalto, G. / Pollicino, T. / Raimondo, G. et al. | 2012
- 862
-
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIHSalmon, D. / Bani-Sadr, F. / Loko, M. A. / Stitou, H. / Gervais, A. / Durant, J. / Rosenthal, E. / Quertainmont, Y. / Barange, K. / Vittecoq, D. et al. | 2012
- 869
-
Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatationAgostini, J. / Benoist, S. / Seman, M. / Julie, C. / Imbeaud, S. / Letourneur, F. / Cagnard, N. / Rougier, P. / Brouquet, A. / Zucman-Rossi, J. et al. | 2012
- 877
-
Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinomaChapman, M. H. / Tidswell, R. / Dooley, J. S. / Sandanayake, N. S. / Cerec, V. / Deheragoda, M. / Lee, A. J. / Swanton, C. / Andreola, F. / Pereira, S. P. et al. | 2012
- 886
-
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelinesTakayasu, K. / Arii, S. / Kudo, M. / Ichida, T. / Matsui, O. / Izumi, N. / Matsuyama, Y. / Sakamoto, M. / Nakashima, O. / Ku, Y. et al. | 2012
- 893
-
Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in miceZhu, Q. / Zou, L. / Jagavelu, K. / Simonetto, D. A. / Huebert, R. C. / Jiang, Z. D. / DuPont, H. L. / Shah, V. H. et al. | 2012
- 900
-
Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat dietsLi, J. / Huang, J. / Li, J. S. / Chen, H. / Huang, K. / Zheng, L. et al. | 2012
- 908
-
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean, A. f. / European, O. f. et al. | 2012
- 944
-
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysisParker, H. M. / Johnson, N. A. / Burdon, C. A. / Cohn, J. S. / O'Connor, H. T. / George, J. et al. | 2012
- 952
-
The interaction of hepatic lipid and glucose metabolism in liver diseasesBechmann, L. P. / Hannivoort, R. A. / Gerken, G. / Hotamisligil, G. S. / Trauner, M. / Canbay, A. et al. | 2012
- 965
-
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosisKisseleva, T. / Brenner, D. A. et al. | 2012
- 973
-
Immunosuppression and HCV recurrence after liver transplantationSamonakis, D. N. / Germani, G. / Burroughs, A. K. et al. | 2012
- 984
-
Chemoembolization for intermediate HCC: Is there proof of survival benefit?Forner, A. / Llovet, J. M. / Bruix, J. et al. | 2012
- 987
-
A lipid to treat non-alcoholic fatty liver disease - The dawn of `lipo-rehabilitation'?Anstee, Q. M. / Day, C. P. et al. | 2012
- 990
-
Snapshot liver transcriptome in hepatocellular carcinomaTeufel, A. / Marquardt, J. U. / Staib, F. / Galle, P. R. et al. | 2012
- 993
-
Platelet function in patients with cirrhosisLisman, T. / Porte, R. J. et al. | 2012
- 994
-
Reply to: Platelet function in patients with cirrhosisVioli, F. / Basili, S. / Raparelli, V. / Chowdary, P. / Gatt, A. / Burroughs, A. K. et al. | 2012
- 995
-
The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver diseaseCross, T. J. et al. | 2012
- 996
-
Reply to: The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver diseasePalmeri, M. L. / Abdelmalek, M. F. / Nightingale, K. R. et al. | 2012
- 996
-
Transplanted hepatocytes: Wiped out or washed out?Alison, M. R. / Marongiu, F. / Laconi, E. et al. | 2012
- 997
-
Entecavir in the treatment of chronic hepatitis B in kidney transplantationRidruejo, E. / Adrover, R. / Mando, O. G. / Silva, M. O. et al. | 2012
- 999
-
Reply to: Entecavir in the treatment of chronic hepatitis B in kidney transplantationVallet-Pichard, A. / Cosconea, S. / Fontaine, H. / Pol, S. et al. | 2012
- 1003
-
Mechanistic biomarkers in acute liver injury: Are we there yet?Adebayo, D. / Mookerjee, R. P. / Jalan, R. et al. | 2012
- 1006
-
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2aRijckborst, V. / Hansen, B. E. / Ferenci, P. / Brunetto, M. R. / Tabak, F. / Cakaloglu, Y. / Lanza, A. G. / Messina, V. / Iannacone, C. / Massetto, B. et al. | 2012
- 1012
-
A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis CThu Thuy, P. T. / Bunchorntavakul, C. / Tan Dat, H. / Rajender Reddy, K. et al. | 2012
- 1019
-
Understanding silibinin's modes of action against HCV using viral kinetic modelingGuedj, J. / Dahari, H. / Pohl, R. T. / Ferenci, P. / Perelson, A. S. et al. | 2012
- 1025
-
Efficacy of non-selective b-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: A randomized controlled trialHung, H. H. / Chang, C. J. / Hou, M. C. / Liao, W. C. / Chan, C. C. / Huang, H. C. / Lin, H. C. / Lee, F. Y. / Lee, S. D. et al. | 2012
- 1033
-
PPARa activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic ratsRodriguez-Vilarrupla, A. / Lavina, B. / Garcia-Caldero, H. / Russo, L. / Rosado, E. / Roglans, N. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2012
- 1040
-
Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective studyPereira, G. / Guevara, M. / Fagundes, C. / Sola, E. / Rodriguez, E. / Fernandez, J. / Pavesi, M. / Arroyo, V. / Gines, P. et al. | 2012
- 1047
-
Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expressionShah, N. / Dhar, D. / El Zahraa Mohammed, F. / Habtesion, A. / Davies, N. A. / Jover-Cobos, M. / Macnaughtan, J. / Sharma, V. / Olde Damink, S. W. / Mookerjee, R. P. et al. | 2012
- 1054
-
The impact of organ dysfunction in cirrhosis: Survival at a cost?Shawcross, D. L. / Austin, M. J. / Abeles, R. D. / McPhail, M. J. / Yeoman, A. D. / Taylor, N. J. / Portal, A. J. / Jamil, K. / Auzinger, G. / Sizer, E. et al. | 2012
- 1063
-
High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitisPischke, S. / Gosling, J. / Engelmann, I. / Schlue, J. / Wolk, B. / Jackel, E. / Meyer-Heithuis, C. / Lehmann, U. / Strassburg, C. P. / Barg-Hock, H. et al. | 2012
- 1070
-
Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicityAntoine, D. J. / Jenkins, R. E. / Dear, J. W. / Williams, D. P. / McGill, M. R. / Sharpe, M. R. / Craig, D. G. / Simpson, K. J. / Jaeschke, H. / Park, B. K. et al. | 2012
- 1080
-
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalysesRaoul, J. L. / Bruix, J. / Greten, T. F. / Sherman, M. / Mazzaferro, V. / Hilgard, P. / Scherubl, H. / Scheulen, M. E. / Germanidis, G. / Dominguez, S. et al. | 2012
- 1089
-
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer populationCucchetti, A. / Trevisani, F. / Cescon, M. / Ercolani, G. / Farinati, F. / Poggio, P. D. / Rapaccini, G. / Nolfo, M. A. / Benvegnu, L. / Zoli, M. et al. | 2012
- 1097
-
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled studyHsu, C. / Yang, T. S. / Huo, T. I. / Hsieh, R. K. / Yu, C. W. / Hwang, W. S. / Hsieh, T. Y. / Huang, W. T. / Chao, Y. / Meng, R. et al. | 2012
- 1104
-
A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stentZhu, H. D. / Guo, J. H. / Zhu, G. Y. / He, S. C. / Fang, W. / Deng, G. / Qin, Y. L. / Li, G. Z. / Coldwell, D. M. / Teng, G. J. et al. | 2012
- 1112
-
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysisMemon, K. / Kulik, L. / Lewandowski, R. J. / Wang, E. / Ryu, R. K. / Riaz, A. / Nikolaidis, P. / Miller, F. H. / Yaghmai, V. / Baker, T. et al. | 2012
- 1121
-
Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study groupChatelain, D. / Farges, O. / Fuks, D. / Trouillet, N. / Pruvot, F. R. / Regimbeau, J. M. et al. | 2012
- 1129
-
Tumor progression-related transmembrane protein aspartate-b-hydroxylase is a target for immunotherapy of hepatocellular carcinomaShimoda, M. / Tomimaru, Y. / Charpentier, K. P. / Safran, H. / Carlson, R. I. / Wands, J. et al. | 2012
- 1136
-
4-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentrationHayashi, H. / Mizuno, T. / Horikawa, R. / Nagasaka, H. / Yabuki, T. / Takikawa, H. / Sugiyama, Y. et al. | 2012
- 1145
-
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-upZelber-Sagi, S. / Lotan, R. / Shlomai, A. / Webb, M. / Harrari, G. / Buch, A. / Nitzan Kaluski, D. / Halpern, Z. / Oren, R. et al. | 2012
- 1152
-
Structural and inflammatory heterogeneity in subcutaneous adipose tissue: Relation with liver histopathology in morbid obesityTordjman, J. / Divoux, A. / Prifti, E. / Poitou, C. / Pelloux, V. / Hugol, D. / Basdevant, A. / Bouillot, J. L. / Chevallier, J. M. / Bedossa, P. et al. | 2012
- 1159
-
Development of the bile ducts: Essentials for the clinical hepatologistStrazzabosco, M. / Fabris, L. et al. | 2012
- 1171
-
Clinical evidence for the regression of liver fibrosisEllis, E. L. / Mann, D. A. et al. | 2012
- 1181
-
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic reviewBoonstra, K. / Beuers, U. / Ponsioen, C. Y. et al. | 2012
- 1189
-
The option of HBIG-free prophylaxis against recurrent HBVFox, A. N. / Terrault, N. A. et al. | 2012
- 1198
-
Cell population genetics and deep sequencing: A novel approach for drivers discovery in hepatocellular carcinomaAlsinet, C. / Villanueva, A. / Llovet, J. M. et al. | 2012
- 1201
-
It's not all in the cilium, but on the road to it: Genetic interaction network in polycystic kidney and liver diseases and how trafficking and quality control matterBergmann, C. / Weiskirchen, R. et al. | 2012
- 1204
-
Histamine regulation of biliary proliferationFrancis, H. / Meng, F. / Gaudio, E. / Alpini, G. et al. | 2012
- 1207
-
Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitisBruns, T. / Reuken, P. A. / Fischer, J. / Berg, T. / Stallmach, A. et al. | 2012
- 1208
-
Reply to: "Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis"Nischalke, H. D. / Grunhage, F. / Spengler, U. / Appenrodt, B. et al. | 2012
- 1209
-
Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patientsValenti, L. / Aghemo, A. / Stattermayer, A. F. et al. | 2012
- 1210
-
Reply to: "Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients"Trepo, E. / Pradat, P. / McCarthy, J. J. / Tillmann, H. L. et al. | 2012
- 1212
-
The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes onManakkat Vijay, G. K. / Taylor, N. J. / Shawcross, D. L. et al. | 2012
- 1213
-
Reply to: "The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on"Tritto, G. / Mookerjee, R. P. / Jalan, R. et al. | 2012
- 1214
-
2prime,7prime-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen speciesReiniers, M. J. / van Golen, R. F. / van Gulik, T. M. / Heger, M. et al. | 2012
- 1216
-
Reply to: "2prime,7prime-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species"Morales, A. / Garcia-Ruiz, C. / Fernandez-Checa, J. C. et al. | 2012
- 1218
-
Erratum to: "Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin" [J Hepatol 2012;56:34-40]Huang, C. F. / Huang, J. F. / Yang, J. F. / Hsieh, M. Y. / Lin, Z. Y. / Chen, S. C. / Wang, L. Y. / Juo, S. H. / Chen, K. C. / Chuang, W. L. et al. | 2012
- 1219
-
Focus:Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: To switch or not to switch?Shouval, D. et al. | 2012
- 1221
-
Gut microbiome and intestinal barrier failure - The "Achilles heel" in hepatology?Benten, D. / Wiest, R. et al. | 2012
- 1224
-
TACE with or without systemic therapy?Dufour, J. F. et al. | 2012
- 1226
-
Control of iron metabolism - Lessons from neonatal hemochromatosisZoller, H. / Knisely, A. S. et al. | 2012
- 1230
-
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotypingVidal-Castineira, J. R. / Lopez-Vazquez, A. / Alonso-Arias, R. / Moro-Garcia, M. A. / Martinez-Camblor, P. / Melon, S. / Prieto, J. / Lopez-Rodriguez, R. / Sanz-Cameno, P. / Rodrigo, L. et al. | 2012
- 1239
-
Peginterferon-a does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitisPenna, A. / Laccabue, D. / Libri, I. / Giuberti, T. / Schivazappa, S. / Alfieri, A. / Mori, C. / Canetti, D. / Lampertico, P. / Vigano, M. et al. | 2012
- 1247
-
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label studyMoreno, C. / Berg, T. / Tanwandee, T. / Thongsawat, S. / Van Vlierberghe, H. / Zeuzem, S. / Lenz, O. / Peeters, M. / Sekar, V. / De Smedt, G. et al. | 2012
- 1254
-
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5yearsFasano, M. / Lampertico, P. / Marzano, A. / Di Marco, V. / Anna Niro, G. / Brancaccio, G. / Marengo, A. / Scotto, G. / Rossana Brunetto, M. / Battista Gaeta, G. et al. | 2012
- 1259
-
Lack of TGF-b production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfectionHarfouch, S. / Guiguet, M. / Valantin, M. A. / Samri, A. / Ouazene, Z. / Slama, L. / Dominguez, S. / Simon, A. / Theodorou, I. / Thibault, V. et al. | 2012
- 1269
-
Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutantsBillioud, G. / Pichoud, C. / Parent, R. / Zoulim, F. et al. | 2012
- 1276
-
Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirinMarcellin, P. / Reau, N. / Ferenci, P. / Hadziyannis, S. / Messinger, D. / Tatsch, F. / Jensen, D. et al. | 2012
- 1283
-
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver diseaseFouts, D. E. / Torralba, M. / Nelson, K. E. / Brenner, D. A. / Schnabl, B. et al. | 2012
- 1293
-
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized studySingh, V. / Ghosh, S. / Singh, B. / Kumar, P. / Sharma, N. / Bhalla, A. / Sharma, A. K. / Choudhary, N. S. / Chawla, Y. / Nain, C. K. et al. | 2012
- 1299
-
C-Reactive protein predicts short-term mortality in patients with cirrhosisCervoni, J. P. / Thevenot, T. / Weil, D. / Muel, E. / Barbot, O. / Sheppard, F. / Monnet, E. / Di Martino, V. et al. | 2012
- 1305
-
The effect of steroid pretreatment of deceased organ donors on liver allograft function: A blinded randomized placebo-controlled trialAmatschek, S. / Wilflingseder, J. / Pones, M. / Kainz, A. / Bodingbauer, M. / Muhlbacher, F. / Langer, R. M. / Gerlei, Z. / Oberbauer, R. et al. | 2012
- 1310
-
Comparison of two non-contemporaneous HCV-liver transplant cohorts: Strategies to improve the efficacy of antiviral therapyBerenguer, M. / Aguilera, V. / Rubin, A. / Ortiz, C. / Jimenez, M. / Prieto, M. et al. | 2012
- 1317
-
Non-invasive diagnosis of hepatocellular carcinoma 2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRIRimola, J. / Forner, A. / Tremosini, S. / Reig, M. / Vilana, R. / Bianchi, L. / Rodriguez-Lope, C. / Sole, M. / Ayuso, C. / Bruix, J. et al. | 2012
- 1324
-
Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinomaJin, Y. J. / Lee, H. C. / Lee, D. / Shim, J. H. / Kim, K. M. / Lim, Y. S. / Do, K. H. / Ryu, J. S. et al. | 2012
- 1330
-
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designBurrel, M. / Reig, M. / Forner, A. / Barrufet, M. / Lope, C. R. / Tremosini, S. / Ayuso, C. / Llovet, J. M. / Real, M. I. / Bruix, J. et al. | 2012
- 1336
-
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinomaPark, J. W. / Koh, Y. H. / Kim, H. B. / Kim, H. Y. / An, S. / Choi, J. I. / Woo, S. M. / Nam, B. H. et al. | 2012
- 1343
-
Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibLachenmayer, A. / Toffanin, S. / Cabellos, L. / Alsinet, C. / Hoshida, Y. / Villanueva, A. / Minguez, B. / Tsai, H. W. / Ward, S. C. / Thung, S. et al. | 2012
- 1351
-
Neonatal iron overload and tissue siderosis due to gestational alloimmune liver diseaseBonilla, S. / Prozialeck, J. D. / Malladi, P. / Pan, X. / Yu, S. / Melin-Aldana, H. / Whitington, P. F. et al. | 2012
- 1356
-
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver diseasePetta, S. / Grimaudo, S. / Camma, C. / Cabibi, D. / Marco, V. D. / Licata, G. / Pipitone, R. M. / Craxi, A. et al. | 2012
- 1363
-
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkersShen, J. / Chan, H. L. / Wong, G. L. / Choi, P. C. / Chan, A. W. / Chan, H. Y. / Chim, A. M. / Yeung, D. K. / Chan, F. K. / Woo, J. et al. | 2012
- 1371
-
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinomaBorel, F. / Konstantinova, P. / Jansen, P. L. et al. | 2012
- 1384
-
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menaceBaffy, G. / Brunt, E. M. / Caldwell, S. H. et al. | 2012
- 1392
-
Adult hepatoblastoma: Learning from childrenRougemont, A. L. / McLin, V. A. / Toso, C. / Wildhaber, B. E. et al. | 2012
- 1404
-
Futility and rationing in liver retransplantation: When and how can we say no?Biggins, S. W. et al. | 2012
- 1412
-
At the cancer steering wheel: Defining key genomic drivers of liver cancer with next generation sequencingBudhu, A. / Wang, X. W. et al. | 2012
- 1415
-
Genetic testing for hepatocellular carcinoma: An ambitious goal still to achieveGalmozzi, E. / Colombo, M. et al. | 2012
- 1417
-
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolutionRamachandran, P. / Iredale, J. P. et al. | 2012
- 1420
-
Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abataceptGermanidis, G. / Hytiroglou, P. / Zakalka, M. / Settas, L. et al. | 2012
- 1422
-
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipientsDonato, M. F. / Galmozzi, E. / Rigamonti, C. / Aghemo, A. et al. | 2012
- 1423
-
Network-based discovery of gene signature for vascular invasion prediction in HCCLiu, W. / He, F. / Jiang, Y. et al. | 2012
- 1424
-
Reply to: "Network-based discovery of gene signature for vascular invasion prediction in HCC"Minguez, B. / Sia, D. / Llovet, J. M. et al. | 2012
- 1425
-
Deregulation of microRNAs expression occurs in stages of multistep hepatocarcinogenesis: Why is it different?Cai, G. / Liu, Y. / Yin, W. et al. | 2012
- 1426
-
Reply to: "Deregulation of microRNAs expression occurs in stages of multistep hepatocarcinogenesis: Why is it different?"Wong, C. M. / Ng, I. O. et al. | 2012
- 1427
-
Is a liver biopsy necessary in alcoholic hepatitis?Forrest, E. H. / Gleeson, D. et al. | 2012
- 1428
-
Reply to: "Is a liver biopsy necessary in alcoholic hepatitis?"Mookerjee, R. P. / Jalan, R. et al. | 2012
- 1430
-
Erratum to: "EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 2012;56:908-943]European, A. f. / European, O. f. et al. | 2012
- I
-
Guide for authors| 2012
- S1
-
Management of bacterial infections in cirrhosisFernandez, J. / Gustot, T. et al. | 2012
- S1
-
2 TMC435 IN HCV GENOTYPE 1 PATIENTS WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON/RIBAVIRIN TREATMENT: FINAL SVR24 RESULTS OF THE ASPIRE TRIALZeuzem, S. / Berg, T. / Gane, E. / Ferenci, P. / Foster, G. R. / Fried, M. W. / Hezode, C. / Hirschfield, G. / Jacobson, I. / Nikitin, I. et al. | 2012
- S2
-
4 DIFFERENT ROLES OF JNK1 AND JNK2 IN THE DEVELOPMENT OF NASH AND HCCCubero, F. J. / Zhao, G. / Nevzorova, Y. A. / Hatting, M. / Drvarov, O. / Masaoudi, M. A. / Gassler, N. / Liedtke, C. / Trautwein, C. et al. | 2012
- S5
-
10 PEGINTERFERON LAMBDA-1A (LAMBDA) COMPARED TO PEGINTERFERON ALFA-2A (ALFA) IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPES (G) 2 OR 3: FIRST SVR24 RESULTS FROM EMERGE PHASE IIBZeuzem, S. / Arora, S. / Bacon, B. / Box, T. / Charlton, M. / Diago, M. / Dieterich, D. / Mur, R. E. / Everson, G. / Fallon, M. et al. | 2012
- S6
-
12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTSNelson, D. R. / Lawitz, E. / Bain, V. / Gitlin, N. / Hawkins, T. / Marotta, P. / Workowski, K. / Flamm, S. / Pang, P. S. / McHutchison, J. G. et al. | 2012
- S7
-
14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRINSuzuki, F. / Ikeda, K. / Toyota, J. / Karino, Y. / Ohmura, T. / Chayama, K. / Takahashi, S. / Kawakami, Y. / Ishikawa, H. / Watanabe, H. et al. | 2012
- S8
-
17 STRAIN-SPECIFIC DISPARITY MODIFIES HEPATOCELLULAR CARCINOMA INITIATION IN ABCB4-DEFICIENT MICEWeber, S. N. / Bohner, A. / Lammert, F. et al. | 2012
- S9
-
20 DEFICIENCIES OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 BETA IN VIVO CAUSES REDUCED SYSTEMIC LIPIDS AND LIPOPROTEINS CONCOMITANT WITH INCREASED HEPATIC APOPTOSIS AND INFLAMMATIONXu, W. / Tuma, S. / Katava, N. / Pathil-Warth, A. / Stremmel, W. / Chamulitrat, W. et al. | 2012
- S11
-
25 SOCIETAL BURDEN IN PATIENTS WITH CHRONIC HEPATIC DISEASES: THE COME STUDY RESULTSFagiuoli, S. / Scalone, L. / Ciampichini, R. / Fusco, F. / Gaeta, L. / Del Prete, A. / Gardini, I. / Mantovani, L. G. et al. | 2012
- S13
-
30 LOW EFFICACY OF CURRENT NUCLEIC ACID TESTING (NAT) ASSAYS FOR THE IDENTIFICATION OF OCCULT HBV INFECTION (OBI) AND CONSEQUENCES FOR SAFETY OF BLOOD SUPPLYSpreafico, M. / Foglieni, B. / Berzuini, A. / Raffaele, L. / Guarnori, I. / Prati, D. et al. | 2012
- S13
-
Management of critically-ill cirrhotic patientsGines, P. / Fernandez, J. / Durand, F. / Saliba, F. et al. | 2012
- S15
-
35 FINE MAPPING OF THE IL-2/IL-21 AND IL2RA LOCI IN PRIMARY SCLEROSING CHOLANGITISSrivastava, B. / Mells, G. / Cordell, H. / Murithii, A. / Brown, M. / Ellinghaus, E. / Franke, A. / Karlsen, T. H. / Sandford, R. / Alexander, G. J. et al. | 2012
- S16
-
37 ACTIVATION OF INTESTINAL FGF15 SIGNALING BY INFLAMMATION LEADS TO CHANGES IN HEPATIC BILE ACID METABOLISM AND A TOXIC BILE PROFILE IN DSS TREATED MICERau, M. / Schmitt, J. / Stieger, B. / Leucht, K. / Cee, A. / Marin, J. J. / Monte, M. J. / Mullhaupt, B. / Rogler, G. / Geier, A. et al. | 2012
- S17
-
40 HLA-B27 HAS A DOMINANT ROLE IN RESTRICTING STRONG CD8+ T CELL RESPONSES AND DRIVING VIRAL ESCAPE IN HEPATITIS B VIRUS INFECTIONKiraithe, M. M. / Nitschke, K. / Price, D. / Gostick, E. / Blum, H. E. / Thimme, R. / Neumann-Haefelin, C. et al. | 2012
- S18
-
42 PEGYLATED-INTERFERON-ALPHA ALONE OR IN COMBINATION WITH ENTECAVIR RESTORES ISG RESPONSIVENESS AND REDUCES INTRAHEPATIC VIRAL LOADS AND ANTIGENEMIA IN HEPATITIS B VIRUS INFECTED HUMANIZED MICEAllweiss, L. / Lutgehetmann, M. / Volz, T. / Bornscheuer, T. / Lohse, A. W. / Petersen, J. / Ma, H. / Klumpp, K. / Fletcher, S. / Dandri, M. et al. | 2012
- S19
-
45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPESchmidt, J. / Iversen, A. K. / Tenzer, S. / Gostick, E. / Price, D. A. / Lohmann, V. / Bowness, P. / Schild, H. / Blum, H. E. / Klenerman, P. et al. | 2012
- S23
-
53 TLR2 AND TLR7/8 ACTIVATION PREDICT POST PARTUM HBV FLARESVisvanathan, K. / Skinner, N. / Locarnini, S. / Bowden, S. / Lewin, S. / Giles, M. / Sasadeusz, J. et al. | 2012
- S25
-
Management of hepatic vascular diseasesPlessier, A. / Rautou, P. E. / Valla, D. C. et al. | 2012
- S28
-
64 HETEROLOGOUS ROLES FOR CASPASE8-SIGNALLING IN HEPATOCYTES AND NON-PARENCHYMAL CELLS IN A MODEL OF LIVER STEM CELL ACTIVATION AND SCLEROSING CHOLANGITISChaudhary, K. / Liedtke, C. / Trautwein, C. / Streetz, K. et al. | 2012
- S29
-
67 LIVER CELL-SPECIFIC PPARg CONDITIONAL-NULL MICE ESTABLISH ANTI-INFLAMMATORY AND ANTI-FIBROGENIC PROPERTIES FOR THIS NUCLEAR RECEPTOR IN KUPFFER CELLSMoran-Salvador, E. / Titos, E. / Gonzalez-Periz, A. / Rius, B. / Garcia-Alonso, V. / Lopez-Vicario, C. / Miquel, R. / Barak, Y. / Arroyo, V. / Claria, J. et al. | 2012
- S30
-
69 CLINICAL PROFILE AND PREDICTORS OF MORTALITY OF ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): A MULTINATIONAL STUDY FROM ASIA PACIFIC REGIONGarg, H. / Kumar, A. / Sarin, S. / Mahtab, M. A. / Rehman, S. / Chawla, Y. / Hamid, S. / Tan, S. S. / Mohamad, R. / de Silva, J. et al. | 2012
- S31
-
72 OUTCOMES OF COMBINATION OF HEPATITIS B IMMUNOGLOBULIN AND HEPATITIS B VACCINATION IN HIGH-RISK NEWBORNS BORN TO HBEAG-POSITIVE MOTHERSLu, S. N. / Wu, C. H. / Ou, C. Y. / Hsu, T. Y. / Chen, C. H. et al. | 2012
- S32
-
74 ROLE OF GENETIC ALTERATION IN MTHFR GENE AND HOMO-CYSTEINE LEVELS AS CRITICAL FACTORS INFLUENCING HEV RELATED PREGNANCY OUTCOMEBaruah, B. / Bose, P. D. / Ray, C. / Bose, M. / Saikia, A. / Deka, M. / Bose, S. et al. | 2012
- S33
-
76 HIRMI VALLEY LIVER DISEASE: A TALE OF TWO TOXINSRobinson, O. / Toledano, M. B. / Goldin, R. / Want, E. / Hauser, M. / Fenwick, A. / Tewelda, Y. / Haweria, Y. G. / Barnabus, G. / Thursz, M. et al. | 2012
- S35
-
81 A ROLE FOR ANTICOAGULATION IN FIBROGENESIS: SUPPRESSION OF HUMAN HEPATIC STELLATE CELL CONTRACTILITY AND LIVER FIBROSIS IN VITRO AND VIVODhar, A. / Anstee, Q. M. / Sadiq, F. / Levene, A. / Cobbold, J. / Petts, G. / Taylor-Robinson, S. / Goldin, R. / Thursz, M. R. et al. | 2012
- S37
-
86 CHARACTERIZATION AND SURVIVAL AFTER LIVER TRANSPLANTATION IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY: A 18 YEARS FOLLOW-UP STUDYBarroso, E. / Cortez-Pinto, H. / Marques, H. P. / Mateus, E. / Pinheiro, L. S. / Gouveia, M. / Costa, J. / Carneiro, A. V. / Borges, M. et al. | 2012
- S38
-
88 CYCLOPHOSPHAMIDE AND NAPROXEN AUGMENT THE METABOLIC EFFECT OF HEPATOCYTE TRANSPLANTATION IN THE GUNN RAT MODEL OF CRIGLER-NAJJAR SYNDROME TYPE 1 BY ENHANCING DONOR CELL ENGRAFTMENTAvsar, Y. / Zhou, H. / Wang, X. / Ding, J. / Guha, C. / Fox, I. J. / Roy-Chowdhury, N. / Roy-Chowdhury, J. et al. | 2012
- S39
-
Management of alcoholic hepatitisMathurin, P. / Lucey, M. R. et al. | 2012
- S39
-
91 TOLL LIKE RECEPTOR 4 ANTAGONIST PREVENTS ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE IN MICE: A NOVEL THERAPEUTIC STRATEGYShah, N. / Dhar, D. / Jover, M. / Davies, N. A. / Mookerjee, R. P. / Jalan, R. et al. | 2012
- S40
-
93 INTERLEUKIN-10 RELEASED BY M2 KUPFFER CELLS PROMOTES M1 KUPFFER CELL APOPTOSIS: A NOVEL PROTECTIVE MECHANISM AGAINST ALCOHOLIC LIVER DISEASEWan, J. / Benkdane, M. / Teixeira-Clerc, F. / Deveaux, V. / Louvet, A. / Lafdil, F. / Pecker, F. / Mallat, A. / Lotersztajn, S. / Pavoine, C. et al. | 2012
- S42
-
98 OPTICAL ANALYSIS OF LIVER MAGNETIC RESONANCE IMAGES BASED ON NEURAL NETWORKS FOR THE DETERMINATION OF FIBROSIS STAGE AND DISTRIBUTION IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Aparcero, R. / Aranda-Guerrero, E. / Gomez-Gonzalez, E. / Rojas, L. / Moreno, I. / Ramirez-Martinez, D. / Fernandez-Arguelles, A. / Gallego-Duran, R. / Pareja, M. J. / Andrade, R. et al. | 2012
- S45
-
102 NK CELL ACTIVITY IN EXPOSED-UNINFECTED PRISON INMATES MAY PROTECT AGAINST HEPATITIS C INFECTIONCameron, B. / Sugden, P. / Lloyd, A. et al. | 2012
- S46
-
105 THE TRANSCRIPTION FACTOR C-JUN REGULATES HEPATOCYTE METABOLISM AND SURVIVAL IN RESPONSE TO b-CATENIN SIGNALING IN THE LIVERTrierweiler, C. / Blum, H. E. / Hasselblatt, P. et al. | 2012
- S46
-
Managing systemic symptoms in chronic liver diseaseNewton, J. L. / Jones, D. E. et al. | 2012
- S47
-
107 LIVER RESECTION AND RADIOFREQUENCY ABLATION IN THE TREATMENT OF SINGLE SMALL (<=3 CM) HEPATOCELLULAR CARCINOMA (HCC): LONG TERM EFFECTIVENESS IN A MULTICENTER SERIESPompili, M. / Saviano, A. / de Matthaeis, N. / Giuliante, F. / Ardito, F. / Federico, B. / Aldrighetti, L. / Brunello, F. / Calise, F. / Capussotti, L. et al. | 2012
- S48
-
109 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPSBronowicki, J. P. / Ye, S. L. / Kudo, M. / Marrero, J. / Dagher, L. / Furuse, J. / Geschwind, J. F. / de Guevara, L. L. / Papandreou, C. / Sanyal, A. J. et al. | 2012
- S49
-
112 URINE PROTEOMIC ANALYSIS DIFFERENTIATES CHOLANGIOCARCINOMA FROM PRIMARY SCLEROSING CHOLANGITIS AND OTHER BENIGN BILIARY DISEASESMetzger, J. / Negm, A. / Plentz, R. / Weismuller, T. / Wedemeyer, J. / Karlsen, T. / Mischak, H. / Manns, M. / Lankisch, T. et al. | 2012
- S50
-
114 OMEPRAZOLE REDUCES THE BACTERICIDAL ACTIVITY OF MONOCYTES AND GRANULOCYTES OF PATIENTS WITH DESCOMPENSATED CIRRHOSIS INDEPENDENTLY OF THE USE OF NORFLOXACINGarcia-Martinez, I. / Frances, R. / Zapater, P. / Gonzalez-Navajas, J. M. / Bellot, P. / Such, J. et al. | 2012
- S52
-
119 THE TRANSCRIPTION FACTOR KLF2 MEDIATES HEPATIC ENDOTHELIAL PROTECTION CONFERRED BY STATINSMarrone, G. / Russo, L. / Rosado, E. / Hide, D. / Garcia-Cardena, G. / Bosch, J. / Garcia-Pagan, J. C. / Gracia-Sancho, J. et al. | 2012
- S54
-
124 HEPATOCYTES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS PERMIT COMPLETE REPLICATION OF THE HEPATITIS C VIRUSRoelandt, P. / Obeid, S. / Vanhove, J. / Paeshuyse, J. / Vanuytsel, K. / Raitano, S. / Van Lommerl, A. / Nahmias, Y. / Neyts, J. / Verfaillie, C. et al. | 2012
- S55
-
127 THE ACTIVATING NK CELL RECEPTOR NKP46 MAY BE INVOLVED IN ANTI-FIBROTIC ACTIVITY OF NK CELLS IN CHRONIC HEPATITIS CKramer, B. / Korner, C. / Zwank, C. / Eisenhardt, M. / Glassner, A. / Kokordelis, P. / Wolter, F. / Nischalke, H. D. / Sauerbruch, T. / Spengler, U. et al. | 2012
- S56
-
The interaction of metabolic factors with HCV infection: Does it matter?Bugianesi, E. / Salamone, F. / Negro, F. et al. | 2012
- S57
-
132 REPEATED TRANSPLANTATION OF HEPATOCYTES RESCUES WILSON S DISEASE WITHOUT PRECONDITIONING OF RECIPIENTSauer, V. / Siaj, R. / Zibert, A. / Stoppeler, S. / Bahde, R. / Spiegel, H. U. / Kohler, G. / Schmidt, H. H. et al. | 2012
- S58
-
135 COMBINED MRNA AND MICRORNA PROFILING REVEALS MICRORNA REGULATION OF LIVER PROGENITOR CELL PHENOTYPEKung, J. W. / Gallagher, I. J. / Forbes, S. J. / Ross, J. A. et al. | 2012
- S62
-
143 STAGE OF BUDD-CHIARI SYNDROME: THE CORRELATION OF IMAGING CLASSIFICATION WITH TREATMENT SELECTION, DISEASE SEVERITY, AND PROGNOSISHan, G. / Zhang, W. / Qi, X. / He, C. / Yin, Z. et al. | 2012
- S63
-
145 CLINICAL FEATURES OF AUTOIMMUNE HEPATITIS IN KOREAN PATIENTS; A NATIONWIDE, MULTICENTER STUDYKim, B. H. / Kim, Y. J. / Jeong, S. H. / Tak, W. Y. / Ahn, S. H. / Lee, Y. J. / Jung, E. U. / Lee, J. I. / Yeon, J. E. / Hwang, J. S. et al. | 2012
- S64
-
148 LOCALLY ACQUIRED HEPATITIS E. GEOGRAPHICAL CLUSTERING AND ENVIRONMENTAL FACTORS: A NESTED CASE CONTROL STUDYMadden, R. G. / Hunter, J. G. / Stone, A. M. / Thornton, C. / Barlow, M. / Lewis, J. / Bendall, R. / Lin, N. / Henley, W. / Dalton, H. R. et al. | 2012
- S65
-
151 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMAPonziani, F. R. / Annichiarico, B. E. / Siciliano, M. / Barone, C. / Basso, M. / Cesario, V. / Campanale, M. / Caracciolo, G. / Garcovich, M. / Zocco, M. et al. | 2012
- S66
-
Anti-fibrotic therapy: Lost in translation?Schuppan, D. / Pinzani, M. et al. | 2012
- S66
-
153 THE DYNAMIC ANALYSIS OF THE TH1/TH2 RATIO DURING THE INTERFERON ALPHA/RIBAVIRIN COMBINATION THERAPY FOR HCV GENOTYPE 6 INFECTED PATIENTSShao, X. / Zhao, Z. / Cai, Q. / Zhang, X. / Gao, Z. et al. | 2012
- S67
-
156 REGIONAL PREVALENCE OF IL28B SNPS RS8099917&RS12979860 IN GENERAL POPULATION AND IN A COHORT OF CHRONIC LIVER DISEASES PATIENTSVassilev, M. / Balabanska, R. / Andonova, S. / Bichev, S. / Tzvetanska, A. / Tzonev, R. / Yourukova, N. / Vassileva, J. / Spassov, L. / Zlatkov, V. et al. | 2012
- S68
-
159 DELAY IN TESTING FOR HEPATITIS DELTA AFTER DIAGNOSING HEPATITIS B - IMPACT ON PROGNOSIS: VIEW FROM LARGE SINGLE CENTER COHORTYesmembetov, K. I. / Mukhin, N. A. / Abdurakhmanov, D. T. et al. | 2012
- S71
-
162 MODELLING OF THE HEPATIC CIRCULATION BY COMBINING VASCULAR CORROSION CASTING AND MICRO-CT IMAGINGDebbaut, C. / Casteleyn, C. / Cornillie, P. / Van Loo, D. / Vierendeels, J. / Segers, P. / Monbaliu, D. et al. | 2012
- S72
-
165 ROLE OF KUPFFER CELLS IN INFLAMMASOME ACTIVATION FOLLOWING HEPATIC ISCHEMIA/REPERFUSIONKim, H. Y. / Kim, K. M. / Kang, J. W. / Lee, S. M. et al. | 2012
- S75
-
173 CONVENTIONAL AND NOVEL CARDIOVASCULAR RISK FACTORS IN LIVER TRANSPLANT RECIPIENTS (LTR)Alvares-da-Silva, M. R. / Oliveira, C. / Stefano, J. T. / Okamatsu, E. / Barbeiro, H. / Barbeiro, D. F. / Soriano, F. / Farias, A. Q. / Carrilho, F. J. / DAlbuquerque, L. A. et al. | 2012
- S75
-
Management of HCCde Lope, C. R. / Tremosini, S. / Forner, A. / Reig, M. / Bruix, J. et al. | 2012
- S76
-
176 LIVER TRANSPLANTATION IN PATIENTS WITH FAMILIAL AMYLOID POLYNEUROPATHY: COMPARISON OF DIFFERENT TRANSTHYRETIN MUTATIONSBarreiros, A. P. / Hoppe-Lotichius, M. / Post, F. / Theis, C. / Geber, C. / Birklein, F. / Galle, P. / Otto, G. et al. | 2012
- S77
-
178 INTRAVENOUS SILIBININ-THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C IN THE TRANSPLANT SETTINGBeinhardt, S. / Rasoul-Rockenschaub, S. / Maieron, A. / Steindl-Munda, P. / Hofer, H. / Ferenci, P. et al. | 2012
- S78
-
181 TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN DURING EARLY ACUTE PHASE OF THE HEPATITIS C RECURRENCE VS LATE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATIONCampos-Varela, I. / Esteban, J. I. / Bilbao, I. / Rodriguez-Frias, F. / Allende, H. / Charco, R. / Esteban, R. / Castells, L. et al. | 2012
- S79
-
184 REGIONAL BODY COMPOSITION CHANGES AFTER LIVER TRANSPLANTATIONCenni, A. / Zappoli, P. / Spinnato, P. / Bazzocchi, A. / Bianchi, G. / Fuzzi, F. / Zoli, M. et al. | 2012
- S80
-
187 ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C: ADVANCED DONOR AGE AND FEMALE RECIPIENT GENDER IDENTIFY NON RESPONDERS AT HIGHER RISK OF GRAFT LOSSCrespo, G. / Marino, Z. / Carrion, J. A. / Garcia-Retortillo, M. / Lens, S. / Miquel, R. / Bosch, J. / Navasa, M. / Forns, X. et al. | 2012
- S82
-
192 HEPATECTOMY IN ELDERLY PATIENTS: STUDY OF FUNCTIONAL HEPATOCELLULAR REGENERATIONFernandes, A. I. / Tralhao, J. G. / Botelho, M. F. / Abrantes, A. M. / Oliveiros, B. / Ferreira, M. / Sousa, F. C. et al. | 2012
- S83
-
195 LONG-TERM OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS B WITH ANTI-HBC POSITIVE GRAFTSGarcia-Eliz, M. / Rubin, A. / Aguilera, V. / Berenguer, M. / Jimenez, N. / Juan, F. S. / Pareja, E. / Lopez-Andujar, R. / Prieto, M. et al. | 2012
- S85
-
200 LEAKING UMBILICAL HERNIA MANAGEMENT IN ASCETIC PATIENTS DUE TO DECOMPENSATED HEPATIC CIRRHOSIS; SAFTY AND OUTCOME OF MODIFIED STONES HERNIORRHAPHY [MSH]Kishta, S. A. et al. | 2012
- S88
-
208 SAFETY OF INTRAOPERATIVE HEMODIALYSIS DURING LIVER TRANSPLANTATION: A 10-YEAR EXPERIENCEMatsuoka, L. / Ananthapanyasut, W. / Boyajian, M. / Kang, S. / Sedra, A. / Genyk, Y. S. / Nadim, M. K. et al. | 2012
- S88
-
Antiviral strategies in hepatitis C virus infectionSarrazin, C. / Hezode, C. / Zeuzem, S. / Pawlotsky, J. M. et al. | 2012
- S89
-
211 LIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASESBhanji, R. A. / Mason, A. L. / Montano-Loza, A. J. et al. | 2012
- S90
-
214 SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION: A SURVEY OF US TRANSPLANT CENTERSNadim, M. K. / Davis, C. / Sung, R. / Kellum, J. A. / Genyk, Y. S. et al. | 2012
- S91
-
216 DEVELOPMENT AND VALIDATION OF PELTQL: A DISEASE-SPECIFIC QUESTIONNAIRE TO MEASURE HEALTH-RELATED QUALITY OF LIFE IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTSNg, V. L. / Andreou, P. / Dhawan, A. / Yazigi, N. / Stormon, M. O. / Ee, L. C. / Gilmour, S. M. / Nicholas, D. / Otley, A. R. et al. | 2012
- S93
-
221 20-YEAR PROTOCOL LIVER BIOPSIES: INVASIVE BUT USEFUL FOR THE MANAGEMENT OF LIVER RECIPIENTSSebagh, M. / Samuel, D. / Antonini, T. M. / Coilly, A. / Degli Esposti, D. / Roche, B. / Karam, V. / Dos Santos, A. / Duclos-Vallee, J. C. / Roque-Afonso, A. M. et al. | 2012
- S94
-
224 TREATMENT BY INTRAOPERATIVE MICROWAVE ABLATION (MCN) ACHIEVED 70% OF 5-YEAR SURVIVAL RATE FOR HCC WITHIN MILAN CRITERIA: MCN AS AN ALTERNATIVE TO LIVER TRANSPLANTATIONTakami, Y. / Saitsu, H. / Tateishi, M. / Ryu, T. / Wada, Y. et al. | 2012
- S96
-
230 ONE-YEAR RESULTS OF TENOFOVIR AND EMTRICITABINE WITHOUT IMMUNOGLOBULIN TO PREVENT HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATIONWesdorp, D. J. / Knoester, M. / Coenraad, M. J. / Braat, A. E. / Claas, E. C. / van Hoek, B. et al. | 2012
- S99
-
238 EXTRACORPOREAL LIVER SUPPORT USING UCL-ARSENEL REDUCES INFLAMMATION, IMPROVES HAEMODYNAMIC FUNCTION AND INCREASE SURVIVAL TIME IN A PORCINE PARACETAMOL-INDUCED ACUTE LIVER FAILURE MODELDavies, N. A. / Leckie, P. / Proven, A. / Thiel, C. / Thiel, K. / Schenk, M. / Flieg, R. / Storr, M. / Jalan, R. et al. | 2012
- S101
-
Trends in liver transplantation 2011Burra, P. / Freeman, R. et al. | 2012
- S102
-
245 NEUTROPHIL INTRACELLULAR TOLL-LIKE RECEPTOR (TLR) 9 EXPRESSION SERVES AS A BIOMARKER THAT DETERMINES PRESENCE AND SEVERITY OF ENCEPHALOPATHY IN ACUTE LIVER FAILURE AND CIRRHOSISVijay, G. K. / Abeles, R. D. / Ramage, S. / Riva, A. / Vergis, N. / Ryan, J. M. / McPhail, M. / Taylor, N. J. / Markwick, L. J. / Wendon, J. A. et al. | 2012
- S104
-
249 IDENTIFICATION AND CHARACTERIZATION OF A NOVEL MONOCYTES SUBPOPULATION IN PERIPHERAL BLOOD OF HEPATITIS B VIRUS-ASSOCIATED ACUTE LIVER FAILURE PATIENTSShen, L. / Wang, J. / Dong, X. / Gong, Y. / Meng, Q. / Wang, X. / Zeng, H. / Li, H. et al. | 2012
- S106
-
253 EPCAM AND AFP AS POOR PROGNOSTIC MARKERS IN PATIENTS WITH HEPATOBLASTOMARagull, S. / Serra, I. / Garrido, M. / Maibach, R. / Io Ng, I. / Czauderna, P. / Bartoli, R. / Planas, R. / Sala, M. / Armengol, C. et al. | 2012
- S108
-
258 CONNECTION BETWEEN WNT/b-CATENIN AND TGF-b/SMADS PATHWAYS IN HEPATOCELLULAR CARCINOMA (HCC): INTERFERON-a2B (IFN) AND TRANSFORMING GROWTH FACTOR-b1 (TGF) TREATMENT EFFECTS ON HCC CELL LINESCeballos, M. P. / Parody, J. P. / Alvarez, M. D. / Ingaramo, P. I. / Carnovale, C. E. / Carrillo, M. C. et al. | 2012
- S109
-
261 LIPID METABOLISM DISORDER AND LIPID SIGNAL TRANSDUCTION PROTEIN FABP EXPRESSION IN HBV ASSOCIATED HEPATOCELLULAR CARCINOMAChen, J. / Xiao, X. / Zhong, Y. / Pan, Y. / Gong, G. et al. | 2012
- S111
-
267 PANOBINOSTAT TREATMENT NEGATIVELY MODULATES ONCOGENIC MIRNAS IN LIVER CANCER CELLSHenrici, A. / Montalbano, R. / Quint, K. / Ocker, M. / Di Fazio, P. et al. | 2012
- S112
-
270 CD44+/EPCAM- PHENOTYPE IN HEPATOCELLULAR CARCINOMA (HCC) CELLS CORRELATES WITH INCREASED AUTOCRINE TGF-BETA AND MESENCHYMAL TRAITSFernando, J. / Alvarez-Barrientos, A. / Cepeda, E. B. / Bertran, E. / Sancho, P. / Fabregat, I. et al. | 2012
- S112
-
Management of treatment failure in chronic hepatitis BZoulim, F. / Locarnini, S. et al. | 2012
- S115
-
279 SIDE POPULATION IN HUMAN HEPATIC CARCINOMAS REFLECTS A POPULATION WITH PROGENITOR CELL FEATURESGovaere, O. / Komuta, M. / Van den Eynde, K. / Wouters, J. / Van den Broeck, A. / Empsen, C. / Gremeaux, L. / Aerts, R. / van Grunsven, L. / Topal, B. et al. | 2012
- S117
-
284 SYNERGISTIC ANTI-TUMOR EFFECT OF ACTIVE IMMUOTHERAPY USING TUMOR LYSATE-PULSED DENDRITIC CELLS AND THYMOSIN a-1 IN A MURINE HEPATOCELLULAR CARCINOMA MODELKim, W. / Kim, D. / Jung, Y. J. et al. | 2012
- S118
-
287 MONOCLONAL ANTIBODY AGAINST CADHERIN-17 AS A POTENTIAL TREATMENT FOR LIVER CANCERLee, N. P. / Wang, Y. / Luk, J. M. et al. | 2012
- S120
-
292 IN HEPATOCELLULAR CARCINOMA MIR-519D IS UPREGULATED BY P53 AND DNA HYPOMETHYLATIONMilazzo, M. / Fornari, F. / Galassi, M. / Negrini, M. / Gramantieri, L. / Bolondi, L. et al. | 2012
- S122
-
297 THE POSTTRANSCRIPTIONAL DYSREGULATION OF METHIONINE ADENOSYL-TRANSFERASES IS CRUCIAL FOR THE PROGRESSION OF RAT AND HUMAN LIVER CANCERMaddalena, F. / Demartis, M. I. / Tomasi, M. L. / Latte, G. / Seddaiu, M. A. / Simile, M. M. / Feo, F. / Pascale, R. M. et al. | 2012
- S123
-
300 INHIBITION OF SIRT1 IMPAIRS THE GROWTH OF HCC TUMOURSPortmann, S. / Fahrner, R. / Lechleiter, A. / Overney, S. / Tschan, M. / Candinas, D. / Stroka, D. et al. | 2012
- S124
-
303 PLASMINOGEN K1-5 STRONGLY DECREASES INTRAHEPATIC SPREAD AND TUMOUR GROWTH IN AN EXPERIMENTAL MOUSE FIBROSIS MODELRaskopf, E. / Sauerbruch, T. / Schmitz, V. et al. | 2012
- S125
-
306 STRATEGY TO OVERCOME CHEMORESISTANCE IN HEPATOCELLULAR TUMOURS BY ENHANCING THE EXPRESSION OF THE DRUG TRANSPORTER OATP1B1Briz, O. / Herraez, E. / Sanchez-Vicente, L. / Vaquero, J. / Lozano, E. / Jimenez, S. / Castano, B. / Marin, J. J. et al. | 2012
- S127
-
311 INFLUENCE OF BLOOD PLASMA LIPOPROTEINS ON MICE HA-1 HEPATOMA CELLS AND METABOLIC PROPERTIES OF TUMOR ASSOCIATED MACROPHAGESSumenkova, D. / Polyakov, L. / Panin, L. et al. | 2012
- S130
-
320 TREATMENT RESPONSE TO SORAFENIB CORRELATES TO DISTINCT TUMOUR MICRO RNA CLUSTERS IN HEPATOCELLULAR CARCINOMAWelker, M. W. / Peveling-Oberhag, J. / Doring, C. / Mertens, A. / Herrmann, E. / Hansmann, M. L. / Zeuzem, S. / Trojan, J. / Kronenberger, B. et al. | 2012
- S131
-
323 ADDITIVE ANTI-TUMOR RESPONSE TO THE RABBIT VX2 HEPATOMA BY COMBINED RADIO FREQUENCY ABLATION AND TOLL LIKE RECEPTOR 9 STIMULATIONWissniowski, T. T. / Ocker, M. / Strobel, D. / Neureiter, D. / Schuppan, D. et al. | 2012
- S132
-
325 HEPATITIS B VIRUS X GENE-UPREGULATED GENE 4 INDUCES CELL PROLIFERATION AND PROMOTES TUMORIGENICITY IN HUMAN HEPATOCELLULAR CARCINOMA THROUGH DOWNREGULATION OF FOXO3AXie, C. / Li, J. / Wu, J. H. / Song, L. B. / Xie, D. Y. / Lin, B. L. / Li, M. F. / Gao, Z. L. et al. | 2012
- S134
-
329 DOWN-REGULATING PIN1 EXPRESSION INHIBITS PROLIFERATION AND INVASION OF HUMAN COLON CANCER SW620 CELLS IN VITROCheng, N. / Li, M. / Hao, H. / Chang, B. / Zhang, Y. et al. | 2012
- S135
-
332 OCOXIN+VIUSID INDUCES APOPTOSIS OF HEPATOMA AND HEPATIC STELLATE CELLS AND POTENTIATES THE EFFECT OF SORAFENIB ON HEPATOMA CELLSArriazu, E. / Ruiz de Galarreta, M. / Perez de Obanos, M. P. / Iraburu, M. et al. | 2012
- S136
-
335 BCL-2 FAMILY MEMBER MCL-1 INTERACTS WITH THE P53 FAMILY OF TRANSCRIPTION FACTORSMeinhard, M. / Koenig, L. / Pelc, A. / Lovas, A. / Joschko, N. / Schulze-Bergkamen, H. H. / Stremmel, W. / Muller, M. et al. | 2012
- S137
-
338 THE SYNERGISTIC EFFECT OF CO-ADMINISTRATION OF HMG-COA REDUCTASE INHIBITOR AND SELECTIVE COX-2 INHIBITOR AGAINST HEPATOCELLULAR CARCINOMA CELLS IS MEDIATED BY INHIBITION OF NF-KB/AKT PATHWAYLee, S. J. / Yim, H. I. / Hwang, J. W. / Lee, H. J. / Yoon, E. L. / Suh, S. J. / Hyun, J. J. / Jung, S. W. / Koo, J. S. / Choung, R. S. et al. | 2012
- S138
-
340 MITOGEN-ACTIVATED PROTEIN KINASES (MAPKS) OF THE P38 AND ERK1/2 TYPES ARE INVOLVED IN ESTRADIOL 17b-D-GLUCURONIDE (E17G)-INDUCED CHOLESTASIS IN RATSBoaglio, A. C. / Toledo, F. D. / Barosso, I. R. / Zucchetti, A. E. / Pozzi, E. J. / Crocenzi, F. A. / Roma, M. G. et al. | 2012
- S139
-
343 HIGH AFFINITY ADENOSINE RECEPTORS MODULATE CNT3 ACTIVITY ON BILIARY EPITHELIAGodoy, V. / Banales, J. M. / Medina, J. F. / Pastor-Anglada, M. et al. | 2012
- S140
-
346 SOMATIC INACTIVATION IN POLYCYSTIC LIVER SEC63 GERMLINE CARRIERS OCCURS THROUGH LOSS OF HETEROZYGOSITYJanssen, M. J. / Salomon, J. / te Morsche, R. H. / Drenth, J. P. et al. | 2012
- S141
-
349 BILE ACIDS DOWNREGULATE THE HUMAN HEPATIC ORGANIC ANION TRANSPORTER 7Jungst, C. / Klein, K. / Eloranta, J. J. / Kullak-Ublick, G. A. et al. | 2012
- S143
-
354 AE2A,B DEFICIENCY MAY LEAD TO VESICULAR TRAFFICKING ALTERATIONS IN MOUSE CHOLANGIOCYTESSanchez de Viteri, M. / Saez, E. / Salas, J. T. / Oude Elferink, R. P. / Prieto, J. / Medina, J. F. / Banales, J. M. et al. | 2012
- S144
-
356 ROLE OF GPR30-ADENYLYL CYCLASE (AC)-PKA PATHWAY IN ESTRADIOL 17b-GLUCURONIDE (E17G) INDUCED CHOLESTASIS IN ISOLATED RAT HEPATOCYTES COUPLETS (IRHC) AND ISOLATED PERFUSED RAT LIVER (IPRL)Zucchetti, A. / Barosso, I. R. / Boaglio, A. C. / Ochoa, E. J. / Davio, C. / Roma, M. G. / Crocenzi, F. A. / Pozzi, E. J. et al. | 2012
- S145
-
359 LOSS OF CDK2 IN HEPATOCYTES LEADS TO INCREASED HEPATIC FIBROGENESIS AFTER CCL4-TREATMENT IN MICEBangen, J. M. / Lambertz, D. / Huss, S. / Barbacid, M. / Trautwein, C. / Liedtke, C. et al. | 2012
- S146
-
361 ENGRAFTMENT AND PROLIFERATION OF TRANSPLANTED HUMAN HEPATIC STELLATE CELLS IN THE LIVER OF IMMUNODEFICIENT MICEBenten, D. / Kluwe, J. / Wirth, J. / Kumaran, V. / Joseph, B. / Volz, T. / Lutgehethmann, M. / Bhargava, K. K. / Cheng, K. / Follenzi, A. et al. | 2012
- S147
-
364 DOWNREGULATION OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) EXPRESSION IN CHRONIC LIVER DISEASE PROMOTES HEPATIC INFLAMMATION AND FIBROSISCzech, B. / Saugspier, M. / Dettmer, K. / Stevens, A. / Dorn, C. / Valletta, D. / Bosserhoff, A. / Oefner, P. J. / Hellerbrand, C. et al. | 2012
- S148
-
367 ROLE OF BETA-ARRESTIN-2 IN THE DEVELOPMENT OF HEPATIC FIBROSISGranzow, M. / Klein, S. / Schierwagen, R. / Heinzen, J. / Huss, S. / Sauerbruch, T. / Trebicka, J. et al. | 2012
- S153
-
381 DLL4 AND JAGGED-1 PROVIDE OPPOSING EFFECTS IN LIVER FIBROSISLiu, Y. / Shen, Z. / Xu, M. Y. / Meyer, C. / Muller, A. / Munker, S. / Li, Q. / Ilkavets, I. / Stump, C. / Mullenbach, R. et al. | 2012
- S154
-
384 HEPCIDIN KNOCKOUT MICE AS A MODEL OF IRON-OVERLOAD ASSOCIATED LIVER FIBROSIS DEVELOPMENTLunova, M. / Vaulont, S. / Lackner, C. / Strnad, P. et al. | 2012
- S156
-
389 OLIGOMERIZATION AND GLYCOSAMINOGLYCAN BINDING OF THE CHEMOKINE CCL5 MEDIATES EXPERIMENTAL LIVER INJURY IN MICENellen, A. / Heinrichs, D. / Fischer, P. / Berres, M. L. / Proudfoot, A. / Trautwein, C. / Wasmuth, H. E. et al. | 2012
- S157
-
392 CXCL9 REDUCES CCL4 INDUCED ANGIOGENESIS AND LIVER FIBROSIS IN VIVOSahin, H. / Schmitz, P. / Fabian, K. / Christian, T. / Wasmuth, H. E. et al. | 2012
- S158
-
395 COX-2 DRIVES THE SELECTIVE INDUCTION OF APOPTOSIS BY THE ENDOCANNABINOID 2-ARACHIDONOYL GLYCEROL IN HEPATIC STELLATE CELLSSiegmund, S. V. / Wojtalla, A. / Schlosser, M. / Sauerbruch, T. / Singer, M. V. et al. | 2012
- S161
-
404 CULTURING ALTERNATIVELY ACTIVATED MACROPHAGES ONTO TYPE III COLLAGEN CAUSES THE DEVELOPMENT OF AN INTERMEDIATE CLASSIC/ALTERNATIVE PHENOTYPEvan Deemter, M. / Ramachandran, P. / Pellicoro, A. / Gordon-Walker, T. T. / Schrader, J. / Iredale, J. P. et al. | 2012
- S162
-
406 NANOPARTICLE LABELING: A NEW ERA IN VIVO TRACING THE CELLS IN LIVER STUDIESAkhan, E. / Aydin, M. M. / Ibrahimova, V. / Bugdayci, E. / Tuncel, D. / Akcali, K. C. et al. | 2012
- S163
-
409 IMPLICATION OF NADPH OXIDASES (NOXES) IN LIVER REGENERATIONCrosas-Molist, E. / Sanchez, A. / Fernandez, M. / Sancho, P. / Bertran, E. / Fabregat, I. et al. | 2012
- S164
-
411 TERLIPRESSIN IMPROVES SURVIVAL AND REGENERATION OF MICE WITH NORMAL AND FATTY LIVER AFTER PARTIAL HEPATECTOMYFahrner, R. / De Gottardi, A. / Stroka, D. / Patsenker, E. / Stickel, F. / Candinas, D. / Beldi, G. et al. | 2012
- S165
-
414 ACTIVATION OF FOXO3 IN THE LIVER INDUCES HYPOGLYCAEMIA AND METABOLIC DYSFUNCTIONGul, S. / Sunami, Y. / Strnad, P. / Bohm, B. / Maier, H. / Wirth, T. et al. | 2012
- S166
-
417 LOSS OF C-MYC DOES NOT PREVENT PROLIFERATION IN HEPATOCYTESHanak, K. / Marhenke, S. / Manns, M. / Vogel, A. / Vogel, A. G. et al. | 2012
- S167
-
420 NON-PARENCHYMAL CELLS REGULATE PROLIFERATION AND DIFFERENTIATION OF HUMAN LIVER PROGENITOR CELLSKung, J. W. / Currie, I. S. / Hadoke, P. W. / Forbes, S. J. / Ross, J. A. et al. | 2012
- S168
-
423 CELL SENESCENCE IN LIVER REPOPULATION AND CARCINOGENESISMarongiu, F. / Serra, M. P. / Sini, M. / Laconi, E. et al. | 2012
- S169
-
426 SORAFENIB DELAYS LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN RATSMollbrink, A. / Augsten, M. / Hultcrantz, R. / Eriksson, L. C. / Stal, P. et al. | 2012
- S170
-
429 MELATONIN ATTENUATES INFLAMMATION AND PROMOTES REGENERATION IN RABBITS WITH FULMINANT HEPATITIS OF VIRAL ORIGINMiguel, B. S. / Crespo, I. / Laliena, A. / Alvarez, M. / Gonzalez-Gallego, J. / Tunon, M. J. et al. | 2012
- S171
-
432 CELL TURNOVER IN THE REPOPULATED RAT LIVER: EVIDENCE AGAINST HEPATOCYTE STREAMINGSerra, M. P. / Sini, M. / Marongiu, F. / Laconi, E. et al. | 2012
- S172
-
434 HEMATOPOIETIC AND ENDOTHELIAL PROGENITOR CELLS AND GROWTH FACTORS IN HUMAN ACUTE HEPATITISSolanas, E. / Aranguren, F. J. / Godino, J. / Moreno, J. A. / De Gregorio, M. A. / Segovia, J. C. / Orman, I. / Lorente, S. / Serrano, M. T. et al. | 2012
- S173
-
437 ANRS 12202: HEPATITIS B AND DELTA HEPATITIS IN CENTRAL AFRICAN REPUBLIC (CAR): VIROLOGICAL REASSESSMENT OF A FULMINANT HEPATITIS OUTBREAK OCCURRING IN THE MID EIGHTIESSamba, D. / Abdou-Chekaraou, M. / Gina, L. / Brichler, S. / Sholtes, C. / Martel, N. / Ouavene, J. O. / Kay, A. / Hantz, O. / Lesbordes, J. L. et al. | 2012
- S174
-
440 EFFECT OF DOSING SCHEDULE ON PHARMACODYNAMIC RESPONSES TO GS-9620 IN CYNOMOLGUS MONKEYSFosdick, A. / Zheng, X. / Tumas, D. / Lopatin, U. / Grushenka, W. et al. | 2012
- S177
-
448 COEXPRESSION OF TIM-3 AND PD-1 IN HBV-SPECIFIC CD8 T CELLS IN PATIENTS WITH HEPATITIS B VIRUS RELATED ACUTE-ON CHRONIC LIVER FAILURELiu, Q. / Li, X. H. / Lin, B. L. / Xie, D. Y. et al. | 2012
- S178
-
451 SUPERINFECTION WITH HDV BUT NOT HBV IN PERMISSIVE HEPATOCYTES EXPRESSING THE LARGE VIRAL SURFACE PROTEINNi, Y. / Hiller, C. / Urban, S. et al. | 2012
- S179
-
454 PRODUCTION AND CHARACTERIZATION OF HEPATOTROPIC HEPATITIS B VIRUS (HBV) PRES1-INTERFERON a (IFNa) FUSIONS FOR TARGETED ANTIVIRAL THERAPIESFilzmayer, C. / Schulze, A. / Ni, Y. / Zawatzky, R. / Lohmann, V. / Koster, M. / Hauser, H. / Urban, S. et al. | 2012
- S180
-
456 PRETREATMENT OF HUMANIZED UPA/SCID MICE WITH INTERFERON ALPHA STRONGLY INHIBITS THE ESTABLISHMENT OF HEPATITIS B VIRUS INFECTIONVolz, T. / Braunschmidt, J. L. / Bornscheuer, T. / Allweiss, L. / Lohse, A. W. / Petersen, J. / Lutgehetmann, M. / Dandri, M. et al. | 2012
- S181
-
459 THE SIGNIFICANCE OF VIRAL AND SEROLOGICAL MARKERS IN PREDICTING LIVER DISEASE SEVERITY IN E-AG NEGATIVE HEPATITIS B VIRUS INFECTIONAudimoolam, V. K. / Carey, I. / Suddle, A. / Bruce, M. / Horner, M. / Agarwal, K. / Harrison, P. M. et al. | 2012
- S183
-
464 CORRELATION BETWEEN CXCR3 LIGANDS AND LIVER INJURY IN TREATMENT NAIVE CHRONIC HEPATITIS B (CHB) PATIENTSHan, Y. / Li, X. H. / Yuan, Z. H. / Zhang, X. X. et al. | 2012
- S184
-
467 DOWNREGULATION OF NK CELL PHENOTYPE AND FUNCTION IN HBV PATIENTS TREATED WITH ENTECAVIRSun, X. / Zhao, P. / Tai, J. / Feng, J. / Niu, J. / Jiang, Y. et al. | 2012
- S185
-
470 PHYLOGENETIC ANALYSES OF HBV PRE-S/S GENES IN MOTHER-CHILD PAIRS WITH LONG-TERM INFECTION BY PRESUMED VERTICAL TRANSMISSIONKim, H. S. / Park, J. W. / Shin, S. R. / Suk, K. T. / Jang, M. K. / Park, S. H. / Kim, D. J. / Lee, M. S. / Park, C. K. et al. | 2012
- S186
-
473 DEVELOPMENT OF PREDICTION MODELS FOR HBV-RELATED LIVER CIRRHOSIS BY INTEGARTING HBV GENOTYPE AND SERUM LEVELS OF HBV DNA AND HBSAGLee, M. H. / Yang, H. I. / Liu, J. / Batrla-Utermann, R. / Jen, C. L. / Iloeje, U. H. / Su, J. / Lu, S. N. / You, S. L. / Wang, L. Y. et al. | 2012
- S187
-
476 RISK OF VERTICAL TRANSMISSION OF HEPATITIS B (HBV) DESPITE NEONATAL PASIVE-ACTIVE IMMUNIZATIONLopez, M. / Gonce, A. / Perez, J. M. / Forns, X. / Mas, A. / Tapias, J. M. / Gratacos, E. et al. | 2012
- S188
-
479 DISCREPANCY OF TREATMENT GUIDELINES AND LIVER BIOPSY FINDINGS IN HEPATITIS B PATIENTSOnder, F. O. / Kabacam, G. / Savas, B. / Etik, D. O. / Oztas, E. / Idilman, R. / Sasmaz, N. / Kayacetin, E. / Yurdaydin, C. et al. | 2012
- S189
-
481 THE USEFULNESS OF TRANSIENT ELASTOGRAPHY (TE) IN THE ACCURATE ASSESSMENT OF PATIENTS WITH HBEAG-NEGATIVE CHRONIC HBV INFECTION (CHBVE-)Papatheodoridis, G. / Margariti, A. / Papageorgiou, M. V. / Kranidioti, H. / Katoglou, A. / Kontos, G. / Kafiri, G. / Pantelidaki, E. / Deutsch, M. / Manolakopoulos, S. et al. | 2012
- S190
-
484 HEPATITIS B CORE-RELATED ANTIGEN AND QUANTITATIVE HEPATITIS B SURFACE ANTIGEN LEVELS IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS B AFTER EXTENDED NUCLEOSIDE ANALOGUES TREATMENTSeo, Y. / Yano, Y. / Miki, A. / Saito, M. / Azuma, T. et al. | 2012
- S191
-
487 KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVOSvicher, V. / Mirabelli, C. / Cento, V. / Salpini, R. / Maio, V. C. / Bertoli, A. / Alteri, C. / Pollicita, M. / Gori, C. / Micheli, V. et al. | 2012
- S194
-
495 CLINICAL FEATURES AND DYNAMIC PATTERNS DURING CLINICAL COURSE OF ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILURE CAN PREDICT THE PROGNOSIS OF ACHBLF: A RETROSPECTIVE COHORT STUDYZheng, Y. B. / Xie, D. Y. / Yan, Y. / Peng, L. / Wu, Z. B. / Lai, J. / Deng, H. / Lin, B. L. / Zhu, R. H. / Chong, Y. T. et al. | 2012
- S197
-
501 CLINICAL, VIROLOGICAL, SEROLOGICAL AND HISTOLOGICAL OUTCOMES IN CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR UP TO 5 YEARSButi, M. / Fung, S. / Gane, E. / Afdhal, N. / Flaherty, J. / Martins, E. / Bekele, N. / Bornstein, J. / Marcellin, P. et al. | 2012
- S198
-
503 NOVEL REVERSE TRANSCRIPTASE MUTATIONS SPECIFICALLY ASSOCIATED WITH SELECTED ANTI-HBV TREATMENT CAN INDUCE ALTERATIONS AND STOP-CODONS IN HBV S ANTIGENCento, V. / Van Hemert, F. / Di Maio, V. C. / Salpini, R. / Mirabelli, C. / Bertoli, A. / Gori, C. / Micheli, V. / Gubertini, G. / Longo, R. et al. | 2012
- S199
-
506 ALISPORIVIR-INDUCED INHIBITION OF CELLULAR CYCLOPHILINS DISRUPTS HEPATITIS B VIRUS (HBV) REPLICATION IN VITRO AND IS SYNERGISTIC IN COMBINATION WITH DIRECT ANTIVIRAL TARGETING HBV-DNA POLYMERASEPhillips, S. / Chokshi, S. / Riva, A. / Naoumov, N. V. et al. | 2012
- S200
-
509 TELBIVUDINE (LDT) TREATMENT EFFECT ON GLOMERULAR FILTRATION RATE (GFR) IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH POTENTIAL RISKS OF RENAL DYSFUNCTIONGane, E. / Amarapurkar, D. / Chen, Y. C. / Yan, Z. / Gerasimova, O. / Tetova, V. / Piratvisuth, T. / Chan, H. L. / Deray, G. / Dong, Y. et al. | 2012
- S201
-
511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSISGoulis, I. / Akriviadis, E. / Karatapanis, S. / Deutsch, M. / Dalekos, G. / Raptopoulou-Gigi, M. / Mimidis, K. / Germanidis, G. / Triantos, C. / Drakoulis, C. et al. | 2012
- S202
-
513 COMPARISON OF TELBIVUDINE USE IN THE 2ND AND 3RD TRIMESTER OF PREGNANCY IN PREVENTING VERTICAL TRANSMISSION IN HIGHLY VIREMIC CHRONIC HEPATITIS B (CHB) MOTHERSHan, G. / Zhao, W. / Ge, C. / Xu, C. / Jiang, H. et al. | 2012
- S203
-
515 VIROLOGICAL BREAKTHROUGH AND GENOTYPIC RESISTANCE IN A RANDOMIZED, CONTROLLED STUDY ON TELBIVUDINE TREATMENT APPLYING ROADMAP CONCEPT IN CHB: W76 INTERIM ANALYSIS OF EFFORT STUDYHou, J. / Sun, J. / Xie, Q. / Tan, D. / Ning, Q. / Niu, J. / Bai, X. / Chen, S. / Cheng, J. / Yu, Y. et al. | 2012
- S205
-
519 A RETROSPECTIVE STUDY OF THE COMPARISONS BETWEEN TELBIVUDINE AND LAMIVUDINE ON THE EFFICACY AND SAFETY IN ANTIVIRAL TREATMENT OF HEPATITIS B VIRUS DURING PREGNANCYJiang, Q. / Yu, M. et al. | 2012
- S206
-
522 MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFILE OF ENTECAVIR MONOTHERAPY IN 418 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A 4-YEAR FIELD PRACTICE, MULTICENTER STUDYLampertico, P. / Soffredini, R. / Invernizzi, F. / Vigano, M. / Facchetti, F. / Minola, E. / Fracassetti, O. / Suter, F. / Zaltron, S. / Vavassori, A. et al. | 2012
- S207
-
524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTSLampertico, P. / Vigano, M. / Costanzo, G. G. / Sagnelli, E. / Fasano, M. / Marco, V. D. / Boninsegna, S. / Farci, P. / Fargion, S. / Giuberti, T. et al. | 2012